{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:31:40Z","timestamp":1792009900773,"version":"4.4.0"},"reference-count":421,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03848-3","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T13:33:23Z","timestamp":1765114403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Advances in nanomedicine-based retinal drug delivery: mechanisms and translational applications"],"prefix":"10.1186","volume":"24","author":[{"given":"Helia","family":"Nafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5250-1542","authenticated-orcid":false,"given":"Pouya","family":"Mahdavi Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-1827","authenticated-orcid":false,"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"issue":"1","key":"3848_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/0974-9233.92115","volume":"19","author":"Y Barak","year":"2012","unstructured":"Barak Y, Heroman WJ, Tezel TH. The past, present, and future of exudative age-related macular degeneration treatment. Middle East Afr J Ophthalmol. 2012;19(1):43\u201351. https:\/\/doi.org\/10.4103\/0974-9233.92115.","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"16","key":"3848_CR2","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.2165\/11538130-000000000-00000","volume":"70","author":"F Boscia","year":"2010","unstructured":"Boscia F. Current approaches to the management of diabetic retinopathy and diabetic macular oedema. Drugs. 2010;70(16):2171\u2013200. https:\/\/doi.org\/10.2165\/11538130-000000000-00000.","journal-title":"Drugs"},{"key":"3848_CR3","doi-asserted-by":"publisher","unstructured":"Barak Y, Heroman Wj, Tezel TH. The past, present, and future of exudative age-related macular degeneration treatment. Middle East Afr J Ophthalmol. 2012(1). https:\/\/doi.org\/10.4103\/0974-9233.92115.","DOI":"10.4103\/0974-9233.92115"},{"key":"3848_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/627674","volume":"2015","author":"V Tah","year":"2015","unstructured":"Tah V, Orlans HO, Hyer J, Casswell E, Din N, Sri Shanmuganathan V, et al. Anti-VEGF therapy and the retina: an update. J Ophthalmol. 2015;2015:627674. https:\/\/doi.org\/10.1155\/2015\/627674.","journal-title":"J Ophthalmol"},{"key":"3848_CR5","first-page":"1","volume-title":"Ocular Transporters and Receptors","author":"K Cholkar","year":"2013","unstructured":"Cholkar K, Dasari SR, Pal D, Mitra AK. 1 - Eye: anatomy, physiology and barriers to drug delivery. In: Mitra AK, editor. Ocular Transporters and Receptors. Woodhead Publishing; 2013. p. 1\u201336."},{"issue":"1","key":"3848_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/14712598.3.1.45","volume":"3","author":"S Duvvuri","year":"2003","unstructured":"Duvvuri S, Majumdar S, Mitra AK. Drug delivery to the retina: challenges and opportunities. Expert Opin Biol Ther. 2003;3(1):45\u201356. https:\/\/doi.org\/10.1517\/14712598.3.1.45.","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"3848_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","volume":"27","author":"KG Falavarjani","year":"2013","unstructured":"Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye Lond. 2013;27(7):787\u201394. https:\/\/doi.org\/10.1038\/eye.2013.107.","journal-title":"Eye Lond"},{"issue":"3\u20134","key":"3848_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.drudis.2007.10.021","volume":"13","author":"SK Sahoo","year":"2008","unstructured":"Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today. 2008;13(3\u20134):144\u201351. https:\/\/doi.org\/10.1016\/j.drudis.2007.10.021.","journal-title":"Drug Discov Today"},{"key":"3848_CR9","doi-asserted-by":"publisher","DOI":"10.4103\/0975-8453.75042","author":"PBSD Patel","year":"2011","unstructured":"Patel PBSD, Shelat PK, Shukla AK. Ophthalmic Drug Delivery System. Challenges and Approaches. 2011. https:\/\/doi.org\/10.4103\/0975-8453.75042.","journal-title":"Challenges and Approaches."},{"key":"3848_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2020.102342","volume":"288","author":"B Grassiri","year":"2021","unstructured":"Grassiri B, Zambito Y, Bernkop-Schn\u00fcrch A. Strategies to prolong the residence time of drug delivery systems on ocular surface. Adv Colloid Interface Sci. 2021;288:102342. https:\/\/doi.org\/10.1016\/j.cis.2020.102342.","journal-title":"Adv Colloid Interface Sci"},{"issue":"8","key":"3848_CR11","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1167\/iovs.02-1068","volume":"44","author":"JL Bourges","year":"2003","unstructured":"Bourges JL, Gautier SE, Delie F, Bejjani RA, Jeanny JC, Gurny R, et al. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci. 2003;44(8):3562\u20139. https:\/\/doi.org\/10.1167\/iovs.02-1068.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3848_CR12","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/s1734-1140(12)70901-5","volume":"64","author":"AZ Wilczewska","year":"2012","unstructured":"Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H. Nanoparticles as drug delivery systems. Pharmacol Rep. 2012;64(5):1020\u201337. https:\/\/doi.org\/10.1016\/s1734-1140(12)70901-5.","journal-title":"Pharmacol Rep"},{"key":"3848_CR13","doi-asserted-by":"publisher","unstructured":"Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215\u201323. https:\/\/doi.org\/10.1016\/j.yexmp.2008.12.004.","DOI":"10.1016\/j.yexmp.2008.12.004"},{"issue":"12","key":"3848_CR14","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1080\/17425247.2016.1201059","volume":"13","author":"L Battaglia","year":"2016","unstructured":"Battaglia L, Serpe L, Foglietta F, Muntoni E, Gallarate M, Del Pozo Rodriguez A, et al. Application of lipid nanoparticles to ocular drug delivery. Expert Opin Drug Deliv. 2016;13(12):1743\u201357. https:\/\/doi.org\/10.1080\/17425247.2016.1201059.","journal-title":"Expert Opin Drug Deliv"},{"key":"3848_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120924","volume":"607","author":"M Mofidfar","year":"2021","unstructured":"Mofidfar M, Abdi B, Ahadian S, Mostafavi E, Desai TA, Abbasi F, et al. Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies. Int J Pharm. 2021;607:120924. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120924.","journal-title":"Int J Pharm"},{"issue":"2","key":"3848_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/0039-6257(81)90145-4","volume":"26","author":"NJ Van Haeringen","year":"1981","unstructured":"Van Haeringen NJ. Clinical biochemistry of tears. Surv Ophthalmol. 1981;26(2):84\u201396. https:\/\/doi.org\/10.1016\/0039-6257(81)90145-4.","journal-title":"Surv Ophthalmol"},{"key":"3848_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2013.10.008","volume":"117","author":"DA Dartt","year":"2013","unstructured":"Dartt DA, Willcox MD. Complexity of the tear film: importance in homeostasis and dysfunction during disease. Exp Eye Res. 2013;117:1\u20133. https:\/\/doi.org\/10.1016\/j.exer.2013.10.008.","journal-title":"Exp Eye Res"},{"issue":"5","key":"3848_CR18","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","volume":"26","author":"R Gaudana","year":"2009","unstructured":"Gaudana R, Jwala J, Boddu SH, Mitra AK. Recent perspectives in ocular drug delivery. Pharm Res. 2009;26(5):1197\u2013216. https:\/\/doi.org\/10.1007\/s11095-008-9694-0.","journal-title":"Pharm Res"},{"issue":"2","key":"3848_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00417-013-2495-0","volume":"252","author":"E Moisseiev","year":"2014","unstructured":"Moisseiev E, Waisbourd M, Ben-Artsi E, Levinger E, Barak A, Daniels T, et al. Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes. Graefes Arch Clin Exp Ophthalmol. 2014;252(2):331\u20137. https:\/\/doi.org\/10.1007\/s00417-013-2495-0.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"3848_CR20","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1167\/iovs.08-3148","volume":"50","author":"H Nomoto","year":"2009","unstructured":"Nomoto H, Shiraga F, Kuno N, Kimura E, Fujii S, Shinomiya K, et al. Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits. Invest Ophthalmol Vis Sci. 2009;50(10):4807\u201313. https:\/\/doi.org\/10.1167\/iovs.08-3148.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"3848_CR21","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1021\/mp500332m","volume":"11","author":"EA Mun","year":"2014","unstructured":"Mun EA, Morrison PW, Williams AC, Khutoryanskiy VV. On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein. Mol Pharm. 2014;11(10):3556\u201364. https:\/\/doi.org\/10.1021\/mp500332m.","journal-title":"Mol Pharm"},{"issue":"4","key":"3848_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.survophthal.2023.02.006","volume":"68","author":"M Soleimani","year":"2023","unstructured":"Soleimani M, Mahdavi Sharif P, Cheraqpour K, Koganti R, Masoumi A, Baharnoori SM, et al. Ocular graft-versus-host disease (oGVHD): from A to Z. Surv Ophthalmol. 2023;68(4):697\u2013712. https:\/\/doi.org\/10.1016\/j.survophthal.2023.02.006.","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"3848_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1517\/17425247.3.2.275","volume":"3","author":"D Ghate","year":"2006","unstructured":"Ghate D, Edelhauser HF. Ocular drug delivery. Expert Opin Drug Deliv. 2006;3(2):275\u201387. https:\/\/doi.org\/10.1517\/17425247.3.2.275.","journal-title":"Expert Opin Drug Deliv"},{"key":"3848_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejpb.2016.10.009","volume":"110","author":"E S\u00e1nchez-L\u00f3pez","year":"2017","unstructured":"S\u00e1nchez-L\u00f3pez E, Espina M, Doktorovova S, Souto EB, Garc\u00eda ML. Lipid nanoparticles (SLN, NLC): overcoming the anatomical and physiological barriers of the eye - Part I - barriers and determining factors in ocular delivery. Eur J Pharm Biopharm. 2017;110:70\u20135. https:\/\/doi.org\/10.1016\/j.ejpb.2016.10.009.","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"3848_CR25","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3109\/03639045.2012.736515","volume":"39","author":"D Achouri","year":"2013","unstructured":"Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm. 2013;39(11):1599\u2013617. https:\/\/doi.org\/10.3109\/03639045.2012.736515.","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"3848_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ejpb.2004.12.007","volume":"60","author":"K Hosoya","year":"2005","unstructured":"Hosoya K, Lee VH, Kim KJ. Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation. Eur J Pharm Biopharm. 2005;60(2):227\u201340. https:\/\/doi.org\/10.1016\/j.ejpb.2004.12.007.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"3848_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/bf02569055","volume":"93","author":"JG Cunha-Vaz","year":"1997","unstructured":"Cunha-Vaz JG. The blood-ocular barriers: past, present, and future. Doc Ophthalmol. 1997;93(1\u20132):149\u201357. https:\/\/doi.org\/10.1007\/bf02569055.","journal-title":"Doc Ophthalmol"},{"issue":"5","key":"3848_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0039-6257(79)90158-9","volume":"23","author":"J Cunha-Vaz","year":"1979","unstructured":"Cunha-Vaz J. The blood-ocular barriers. Surv Ophthalmol. 1979;23(5):279\u201396. https:\/\/doi.org\/10.1016\/0039-6257(79)90158-9.","journal-title":"Surv Ophthalmol"},{"key":"3848_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/978-1-4614-4711-5_3","volume":"763","author":"M Campbell","year":"2012","unstructured":"Campbell M, Humphries P. The blood-retina barrier: tight junctions and barrier modulation. Adv Exp Med Biol. 2012;763:70\u201384.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"3848_CR30","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/febs.16330","volume":"290","author":"F O'Leary","year":"2023","unstructured":"O\u2019Leary F, Campbell M. The blood-retina barrier in health and disease. FEBS J. 2023;290(4):878\u201391. https:\/\/doi.org\/10.1111\/febs.16330.","journal-title":"FEBS J"},{"issue":"1","key":"3848_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12951-020-00745-9","volume":"19","author":"S Swetledge","year":"2021","unstructured":"Swetledge S, Jung JP, Carter R, Sabliov C. Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy. J Nanobiotechnol. 2021;19(1):10. https:\/\/doi.org\/10.1186\/s12951-020-00745-9.","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"3848_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1517\/17425240902762818","volume":"6","author":"P Paolicelli","year":"2009","unstructured":"Paolicelli P, de la Fuente M, S\u00e1nchez A, Seijo B, Alonso MJ. Chitosan nanoparticles for drug delivery to the eye. Expert Opinion on Drug Delivery. 2009;6(3):239\u201353. https:\/\/doi.org\/10.1517\/17425240902762818.","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"1","key":"3848_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2023.2204206","volume":"30","author":"H Jiang","year":"2023","unstructured":"Jiang H, Xu Z. Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment. Drug Deliv. 2023;30(1):2204206. https:\/\/doi.org\/10.1080\/10717544.2023.2204206.","journal-title":"Drug Deliv"},{"key":"3848_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2147\/ijn.S30725","volume":"8","author":"M Honda","year":"2013","unstructured":"Honda M, Asai T, Oku N, Araki Y, Tanaka M, Ebihara N. Liposomes and nanotechnology in drug development: focus on ocular targets. Int J Nanomed. 2013;8:495\u2013503. https:\/\/doi.org\/10.2147\/ijn.S30725.","journal-title":"Int J Nanomed"},{"key":"3848_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jconrel.2023.08.018","volume":"362","author":"KK Abla","year":"2023","unstructured":"Abla KK, Mehanna MM. Lipid-based nanocarriers challenging the ocular biological barriers: current paradigm and future perspectives. J Control Release. 2023;362:70\u201396. https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.018.","journal-title":"J Control Release"},{"key":"3848_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.931759","volume":"9","author":"C Yang","year":"2022","unstructured":"Yang C, Yang J, Lu A, Gong J, Yang Y, Lin X, et al. Nanoparticles in ocular applications and their potential toxicity. Front Mol Biosci. 2022;9:931759. https:\/\/doi.org\/10.3389\/fmolb.2022.931759.","journal-title":"Front Mol Biosci"},{"issue":"50","key":"3848_CR37","doi-asserted-by":"publisher","first-page":"505101","DOI":"10.1088\/0957-4484\/20\/50\/505101","volume":"20","author":"JH Kim","year":"2009","unstructured":"Kim JH, Kim JH, Kim KW, Kim MH, Yu YS. Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity. Nanotechnology. 2009;20(50):505101. https:\/\/doi.org\/10.1088\/0957-4484\/20\/50\/505101.","journal-title":"Nanotechnology"},{"issue":"6","key":"3848_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/jop.2019.0105","volume":"36","author":"R Maccarone","year":"2020","unstructured":"Maccarone R, Tisi A, Passacantando M, Ciancaglini M. Ophthalmic applications of Cerium oxide nanoparticles. J Ocul Pharmacol Ther. 2020;36(6):376\u201383. https:\/\/doi.org\/10.1089\/jop.2019.0105.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3848_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/antiox5020015","author":"BC Nelson","year":"2016","unstructured":"Nelson BC, Johnson ME, Walker ML, Riley KR, Sims CM. Antioxidant cerium oxide nanoparticles in biology and medicine. Antioxidants. 2016. https:\/\/doi.org\/10.3390\/antiox5020015.","journal-title":"Antioxidants"},{"issue":"1","key":"3848_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12951-023-01992-2","volume":"21","author":"S Li","year":"2023","unstructured":"Li S, Chen L, Fu Y. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects. J Nanobiotechnol. 2023;21(1):232. https:\/\/doi.org\/10.1186\/s12951-023-01992-2.","journal-title":"J Nanobiotechnol"},{"key":"3848_CR41","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.biopha.2018.08.138","volume":"107","author":"K Nayak","year":"2018","unstructured":"Nayak K, Misra M. A review on recent drug delivery systems for posterior segment of eye. Biomed Pharmacother. 2018;107:1564\u201382. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.138.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"3848_CR42","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.drudis.2019.03.023","volume":"24","author":"Y Agban","year":"2019","unstructured":"Agban Y, Thakur SS, Mugisho OO, Rupenthal ID. Depot formulations to sustain periocular drug delivery to the posterior eye segment. Drug Discov Today. 2019;24(8):1458\u201369. https:\/\/doi.org\/10.1016\/j.drudis.2019.03.023.","journal-title":"Drug Discov Today"},{"issue":"1","key":"3848_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1517\/17425247.1.1.99","volume":"1","author":"S Raghava","year":"2004","unstructured":"Raghava S, Hammond M, Kompella UB. Periocular routes for retinal drug delivery. Expert Opin Drug Deliv. 2004;1(1):99\u2013114. https:\/\/doi.org\/10.1517\/17425247.1.1.99.","journal-title":"Expert Opin Drug Deliv"},{"issue":"7","key":"3848_CR44","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/IAE.0b013e3181a94f01","volume":"29","author":"GA Peyman","year":"2009","unstructured":"Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina. 2009;29(7):875\u2013912. https:\/\/doi.org\/10.1097\/IAE.0b013e3181a94f01.","journal-title":"Retina"},{"issue":"10","key":"3848_CR45","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1517\/17425247.2014.927864","volume":"11","author":"SS Thakur","year":"2014","unstructured":"Thakur SS, Barnett NL, Donaldson MJ, Parekh HS. Intravitreal drug delivery in retinal disease: are we out of our depth? Expert Opin Drug Deliv. 2014;11(10):1575\u201390. https:\/\/doi.org\/10.1517\/17425247.2014.927864.","journal-title":"Expert Opin Drug Deliv"},{"key":"3848_CR46","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2147\/opth.S207978","volume":"14","author":"M Schargus","year":"2020","unstructured":"Schargus M, Frings A. Issues with intravitreal administration of anti-VEGF drugs. Clin Ophthalmol. 2020;14:897\u2013904. https:\/\/doi.org\/10.2147\/opth.S207978.","journal-title":"Clin Ophthalmol"},{"key":"3848_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020265","author":"D Veritti","year":"2022","unstructured":"Veritti D, Sarao V, Gorni G, Lanzetta P. Anti-VEGF drugs dynamics: relevance for clinical practice. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14020265.","journal-title":"Pharmaceutics"},{"issue":"4","key":"3848_CR48","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41433-019-0584-y","volume":"34","author":"E Moisseiev","year":"2020","unstructured":"Moisseiev E, Loewenstein A. Abicipar pegol\u2014a novel anti-VEGF therapy with a long duration of action. Eye. 2020;34(4):605\u20136. https:\/\/doi.org\/10.1038\/s41433-019-0584-y.","journal-title":"Eye"},{"issue":"2","key":"3848_CR49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/ijn.s596","volume":"3","author":"WH De Jong","year":"2008","unstructured":"De Jong WH, Borm PJ. Drug delivery and nanoparticles:applications and hazards. Int J Nanomed. 2008;3(2):133\u201349. https:\/\/doi.org\/10.2147\/ijn.s596.","journal-title":"Int J Nanomed"},{"issue":"10","key":"3848_CR50","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/s0161-6420(02)01146-6","volume":"109","author":"R Klein","year":"2002","unstructured":"Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: the beaver dam eye study. Ophthalmology. 2002;109(10):1767\u201379. https:\/\/doi.org\/10.1016\/s0161-6420(02)01146-6.","journal-title":"Ophthalmology"},{"issue":"3","key":"3848_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0039-6257(03)00030-4","volume":"48","author":"J Ambati","year":"2003","unstructured":"Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48(3):257\u201393. https:\/\/doi.org\/10.1016\/s0039-6257(03)00030-4.","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"3848_CR52","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrn2007","volume":"7","author":"A Rattner","year":"2006","unstructured":"Rattner A, Nathans J. Macular degeneration: recent advances and therapeutic opportunities. Nat Rev Neurosci. 2006;7(11):860\u201372. https:\/\/doi.org\/10.1038\/nrn2007.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"3848_CR53","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.mam.2012.03.009","volume":"33","author":"SG Jarrett","year":"2012","unstructured":"Jarrett SG, Boulton ME. Consequences of oxidative stress in age-related macular degeneration. Mol Aspects Med. 2012;33(4):399\u2013417. https:\/\/doi.org\/10.1016\/j.mam.2012.03.009.","journal-title":"Mol Aspects Med"},{"key":"3848_CR54","doi-asserted-by":"publisher","first-page":"7901270","DOI":"10.1155\/2020\/7901270","volume":"2020","author":"S Abokyi","year":"2020","unstructured":"Abokyi S, To CH, Lam TT, Tse DY. Central role of oxidative stress in Age-Related macular degeneration: evidence from a review of the molecular mechanisms and animal models. Oxid Med Cell Longev. 2020;2020:7901270. https:\/\/doi.org\/10.1155\/2020\/7901270.","journal-title":"Oxid Med Cell Longev"},{"key":"3848_CR55","doi-asserted-by":"publisher","first-page":"7836828","DOI":"10.1155\/2022\/7836828","volume":"2022","author":"J Wang","year":"2022","unstructured":"Wang J, Li M, Geng Z, Khattak S, Ji X, Wu D, et al. Role of oxidative stress in retinal disease and the early intervention strategies: A review. Oxid Med Cell Longev. 2022;2022:7836828. https:\/\/doi.org\/10.1155\/2022\/7836828.","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"3848_CR56","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1159\/000517520","volume":"244","author":"R Flores","year":"2021","unstructured":"Flores R, Carneiro \u00c2, Vieira M, Tenreiro S, Seabra MC. Age-related macular degeneration: pathophysiology, management, and future perspectives. Ophthalmologica. 2021;244(6):495\u2013511. https:\/\/doi.org\/10.1159\/000517520.","journal-title":"Ophthalmologica"},{"key":"3848_CR57","doi-asserted-by":"publisher","unstructured":"Stewart MW. The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clin Proc. 2012;87(1):77\u201388. https:\/\/doi.org\/10.1016\/j.mayocp.2011.10.001.","DOI":"10.1016\/j.mayocp.2011.10.001"},{"key":"3848_CR58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","volume":"2","author":"R Lee","year":"2015","unstructured":"Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17. https:\/\/doi.org\/10.1186\/s40662-015-0026-2.","journal-title":"Eye Vis (Lond)"},{"key":"3848_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061816","author":"W Wang","year":"2018","unstructured":"Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19061816.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3848_CR60","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/jdi.13480","volume":"12","author":"KY Lin","year":"2021","unstructured":"Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322\u20135. https:\/\/doi.org\/10.1111\/jdi.13480.","journal-title":"J Diabetes Investig"},{"key":"3848_CR61","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","volume":"48","author":"R Sim\u00f3","year":"2015","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res. 2015;48:160\u201380. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.04.003.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"3848_CR62","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/eye.2014.13","volume":"28","author":"P Osaadon","year":"2014","unstructured":"Osaadon P, Fagan XJ, Lifshitz T, Levy J. A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond). 2014;28(5):510\u201320. https:\/\/doi.org\/10.1038\/eye.2014.13.","journal-title":"Eye (Lond)"},{"key":"3848_CR63","doi-asserted-by":"publisher","unstructured":"Vaziri K, Schwartz SG, Relhan N, Kishor KS, Flynn HW Jr. New therapeutic approaches in diabetic retinopathy. Rev Diabet Stud. 2015;12(1\u20132):196\u2013210. https:\/\/doi.org\/10.1900\/rds.2015.12.196.","DOI":"10.1900\/rds.2015.12.196"},{"key":"3848_CR64","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8193523","volume":"2018","author":"L Lu","year":"2018","unstructured":"Lu L, Lu Q, Chen W, Li J, Li C, Zheng Z. Vitamin D(3) protects against diabetic retinopathy by inhibiting high-glucose-induced activation of the ROS\/TXNIP\/NLRP3 inflammasome pathway. J Diabetes Res. 2018;2018:8193523. https:\/\/doi.org\/10.1155\/2018\/8193523.","journal-title":"J Diabetes Res"},{"key":"3848_CR65","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fphar.2017.00798","volume":"8","author":"SV Suryavanshi","year":"2017","unstructured":"Suryavanshi SV, Kulkarni YA. NF-\u03ba\u03b2: a potential target in the management of vascular complications of diabetes. Front Pharmacol. 2017;8:798. https:\/\/doi.org\/10.3389\/fphar.2017.00798.","journal-title":"Front Pharmacol"},{"issue":"2","key":"3848_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/s1098-3597(03)90015-9","volume":"5","author":"S Lightman","year":"2003","unstructured":"Lightman S, Towler HM. Diabetic retinopathy. Clin Cornerstone. 2003;5(2):12\u201321. https:\/\/doi.org\/10.1016\/s1098-3597(03)90015-9.","journal-title":"Clin Cornerstone"},{"key":"3848_CR67","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2156273","volume":"2016","author":"P Romero-Aroca","year":"2016","unstructured":"Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R. Diabetic macular edema pathophysiology: vasogenic versus inflammatory. J Diabetes Res. 2016;2016:2156273. https:\/\/doi.org\/10.1155\/2016\/2156273.","journal-title":"J Diabetes Res"},{"issue":"9","key":"3848_CR68","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11892-019-1188-4","volume":"19","author":"EJ Kim","year":"2019","unstructured":"Kim EJ, Lin WV, Rodriguez SM, Chen A, Loya A, Weng CY. Treatment of diabetic macular edema. Curr Diab Rep. 2019;19(9):68. https:\/\/doi.org\/10.1007\/s11892-019-1188-4.","journal-title":"Curr Diab Rep"},{"issue":"10414","key":"3848_CR69","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/s0140-6736(23)01289-8","volume":"402","author":"H Jayaram","year":"2023","unstructured":"Jayaram H, Kolko M, Friedman DS, Gazzard G. Glaucoma: now and beyond. Lancet. 2023;402(10414):1788\u2013801. https:\/\/doi.org\/10.1016\/s0140-6736(23)01289-8.","journal-title":"Lancet"},{"issue":"4","key":"3848_CR70","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.survophthal.2021.12.003","volume":"67","author":"WS Shalaby","year":"2022","unstructured":"Shalaby WS, Ahmed OM, Waisbourd M, Katz LJ. A review of potential novel glaucoma therapeutic options independent of intraocular pressure. Surv Ophthalmol. 2022;67(4):1062\u201380. https:\/\/doi.org\/10.1016\/j.survophthal.2021.12.003.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"3848_CR71","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12325-019-01163-6","volume":"37","author":"ML Occhiutto","year":"2020","unstructured":"Occhiutto ML, Maranh\u00e3o RC, Costa VP, Konstas AG. Nanotechnology for medical and surgical glaucoma therapy-a review. Adv Ther. 2020;37(1):155\u201399. https:\/\/doi.org\/10.1007\/s12325-019-01163-6.","journal-title":"Adv Ther"},{"issue":"4","key":"3848_CR72","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/138920211795860107","volume":"12","author":"S Ferrari","year":"2011","unstructured":"Ferrari S, Di Iorio E, Barbaro V, Ponzin D, Sorrentino FS, Parmeggiani F. Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics. 2011;12(4):238\u201349. https:\/\/doi.org\/10.2174\/138920211795860107.","journal-title":"Curr Genomics"},{"key":"3848_CR73","doi-asserted-by":"publisher","unstructured":"Nguyen XT, Moekotte L, Plomp AS, Bergen AA, van Genderen MM, Boon CJF. Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies. Int J Mol Sci. 2023;24(8). https:\/\/doi.org\/10.3390\/ijms24087481.","DOI":"10.3390\/ijms24087481"},{"issue":"8","key":"3848_CR74","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/aos.13141","volume":"94","author":"DS Narayan","year":"2016","unstructured":"Narayan DS, Wood JP, Chidlow G, Casson RJ. A review of the mechanisms of cone degeneration in retinitis pigmentosa. Acta Ophthalmol. 2016;94(8):748\u201354. https:\/\/doi.org\/10.1111\/aos.13141.","journal-title":"Acta Ophthalmol"},{"key":"3848_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094883","author":"W Liu","year":"2022","unstructured":"Liu W, Liu S, Li P, Yao K. Retinitis pigmentosa: progress in molecular pathology and biotherapeutical strategies. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23094883.","journal-title":"Int J Mol Sci"},{"key":"3848_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020685","author":"KY Wu","year":"2023","unstructured":"Wu KY, Kulbay M, Toameh D, Xu AQ, Kalevar A, Tran SD. Retinitis pigmentosa: novel therapeutic targets and drug development. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15020685.","journal-title":"Pharmaceutics"},{"key":"3848_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60010189","author":"EM Vingolo","year":"2024","unstructured":"Vingolo EM, Mascolo S, Miccich\u00e8 F, Manco G. Retinitis pigmentosa: from pathomolecular mechanisms to therapeutic strategies. Medicina (Kaunas). 2024. https:\/\/doi.org\/10.3390\/medicina60010189.","journal-title":"Medicina (Kaunas)"},{"issue":"10097","key":"3848_CR78","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017;390(10097):849\u201360. https:\/\/doi.org\/10.1016\/s0140-6736(17)31868-8.","journal-title":"Lancet"},{"issue":"5","key":"3848_CR79","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18(5):358\u201378. https:\/\/doi.org\/10.1038\/s41573-019-0012-9.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"3848_CR80","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s10653-020-00766-1","volume":"43","author":"R Singh","year":"2021","unstructured":"Singh R, Bhateria R. Core-shell nanostructures: a simplest two-component system with enhanced properties and multiple applications. Environ Geochem Health. 2021;43(7):2459\u201382. https:\/\/doi.org\/10.1007\/s10653-020-00766-1.","journal-title":"Environ Geochem Health"},{"issue":"1","key":"3848_CR81","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12951-022-01477-8","volume":"20","author":"N Joudeh","year":"2022","unstructured":"Joudeh N, Linke D. Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. J Nanobiotechnol. 2022;20(1):262. https:\/\/doi.org\/10.1186\/s12951-022-01477-8.","journal-title":"J Nanobiotechnol"},{"issue":"1\u20132","key":"3848_CR82","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ijpharm.2018.06.025","volume":"547","author":"Y Lv","year":"2018","unstructured":"Lv Y, He H, Qi J, Lu Y, Zhao W, Dong X, et al. Visual validation of the measurement of entrapment efficiency of drug nanocarriers. Int J Pharm. 2018;547(1\u20132):395\u2013403. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.06.025.","journal-title":"Int J Pharm"},{"issue":"6","key":"3848_CR83","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.18240\/ijo.2018.06.23","volume":"11","author":"S Jiang","year":"2018","unstructured":"Jiang S, Franco YL, Zhou Y, Chen J. Nanotechnology in retinal drug delivery. Int J Ophthalmol. 2018;11(6):1038\u201344. https:\/\/doi.org\/10.18240\/ijo.2018.06.23.","journal-title":"Int J Ophthalmol"},{"key":"3848_CR84","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jconrel.2020.10.028","volume":"328","author":"S Tavakoli","year":"2020","unstructured":"Tavakoli S, Peynshaert K, Lajunen T, Devoldere J, Del Amo EM, Ruponen M, et al. Ocular barriers to retinal delivery of intravitreal liposomes: impact of vitreoretinal interface. J Control Release. 2020;328:952\u201361. https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.028.","journal-title":"J Control Release"},{"issue":"4","key":"3848_CR85","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jphp.12132","volume":"66","author":"JG Souza","year":"2014","unstructured":"Souza JG, Dias K, Pereira TA, Bernardi DS, Lopez RF. Topical delivery of ocular therapeutics: carrier systems and physical methods. J Pharm Pharmacol. 2014;66(4):507\u201330. https:\/\/doi.org\/10.1111\/jphp.12132.","journal-title":"J Pharm Pharmacol"},{"issue":"11","key":"3848_CR86","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2174\/0929866521666140807114240","volume":"21","author":"A Patel","year":"2014","unstructured":"Patel A, Patel M, Yang X, Mitra AK. Recent advances in protein and peptide drug delivery: a special emphasis on polymeric nanoparticles. Protein Pept Lett. 2014;21(11):1102\u201320. https:\/\/doi.org\/10.2174\/0929866521666140807114240.","journal-title":"Protein Pept Lett"},{"key":"3848_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/nano10071403","author":"B Begines","year":"2020","unstructured":"Begines B, Ortiz T, P\u00e9rez-Aranda M, Mart\u00ednez G, Merinero M, Arg\u00fcelles-Arias F, et al. Polymeric nanoparticles for drug delivery: recent developments and future prospects. Nanomaterials. 2020. https:\/\/doi.org\/10.3390\/nano10071403.","journal-title":"Nanomaterials"},{"issue":"3","key":"3848_CR88","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polym Basel. 2011;3(3):1377\u201397. https:\/\/doi.org\/10.3390\/polym3031377.","journal-title":"Polym Basel"},{"issue":"2","key":"3848_CR89","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2012.01.043.","journal-title":"J Control Release"},{"issue":"4","key":"3848_CR90","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2174\/2211738510666220806102612","volume":"10","author":"NR Gogoi","year":"2022","unstructured":"Gogoi NR, Marbaniang D, Pal P, Ray S, Mazumder B. Targeted nanotherapies for the posterior segment of the eye: an integrative review on recent advancements and challenges. Pharm Nanotechnol. 2022;10(4):268\u201378. https:\/\/doi.org\/10.2174\/2211738510666220806102612.","journal-title":"Pharm Nanotechnol"},{"key":"3848_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122728","author":"HO Alsaab","year":"2022","unstructured":"Alsaab HO, Alharbi FD, Alhibs AS, Alanazi NB, Alshehri BY, Saleh MA, et al. PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14122728.","journal-title":"Pharmaceutics"},{"issue":"10","key":"3848_CR92","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1002\/jbm.a.35446","volume":"103","author":"R Varshochian","year":"2015","unstructured":"Varshochian R, Riazi-Esfahani M, Jeddi-Tehrani M, Mahmoudi AR, Aghazadeh S, Mahbod M, et al. Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment. J Biomed Mater Res A. 2015;103(10):3148\u201356. https:\/\/doi.org\/10.1002\/jbm.a.35446.","journal-title":"J Biomed Mater Res A"},{"key":"3848_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020243","author":"JS Alanazi","year":"2022","unstructured":"Alanazi JS, Alqahtani FY, Aleanizy FS, Radwan AA, Bari A, Alqahtani QH, et al. MicroRNA-539-5p-loaded PLGA nanoparticles grafted with iRGD as a targeting treatment for choroidal neovascularization. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14020243.","journal-title":"Pharmaceutics"},{"key":"3848_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/polym13040642","author":"XL Hsu","year":"2021","unstructured":"Hsu XL, Wu LC, Hsieh JY, Huang YY. Nanoparticle-hydrogel composite drug delivery system for potential ocular applications. Polymers. 2021. https:\/\/doi.org\/10.3390\/polym13040642.","journal-title":"Polymers"},{"key":"3848_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ph17040481","author":"A Krishnan","year":"2024","unstructured":"Krishnan A, Callanan DG, Sendra VG, Lad A, Christian S, Earla R, et al. Comprehensive ocular and systemic safety evaluation of polysialic acid-decorated immune modulating therapeutic nanoparticles (PolySia-NPs) to support entry into first-in-human clinical trials. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17040481.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"3848_CR96","doi-asserted-by":"publisher","first-page":"820","DOI":"10.2174\/0929867329666220729153654","volume":"30","author":"A Davoodvandi","year":"2023","unstructured":"Davoodvandi A, Sharif PM, Dana PM, Asemi Z. Resveratrol effects on molecular pathways and MicroRNAs in gastrointestinal cancers. Curr Med Chem. 2023;30(7):820\u201340. https:\/\/doi.org\/10.2174\/0929867329666220729153654.","journal-title":"Curr Med Chem"},{"issue":"8","key":"3848_CR97","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1208\/s12249-020-01836-4","volume":"21","author":"P Bhatt","year":"2020","unstructured":"Bhatt P, Fnu G, Bhatia D, Shahid A, Sutariya V. Nanodelivery of resveratrol-loaded PLGA nanoparticles for age-related macular degeneration. AAPS PharmSciTech. 2020;21(8):291. https:\/\/doi.org\/10.1208\/s12249-020-01836-4.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"3848_CR98","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/nu5051823","volume":"5","author":"K Koushan","year":"2013","unstructured":"Koushan K, Rusovici R, Li W, Ferguson LR, Chalam KV. The role of lutein in eye-related disease. Nutrients. 2013;5(5):1823\u201339. https:\/\/doi.org\/10.3390\/nu5051823.","journal-title":"Nutrients"},{"key":"3848_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12090798","author":"PK Bolla","year":"2020","unstructured":"Bolla PK, Gote V, Singh M, Patel M, Clark BA, Renukuntla J. Lutein-loaded, biotin-decorated polymeric nanoparticles enhance lutein uptake in retinal cells. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12090798.","journal-title":"Pharmaceutics"},{"key":"3848_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/md18050239","author":"G Giannaccare","year":"2020","unstructured":"Giannaccare G, Pellegrini M, Senni C, Bernabei F, Scorcia V, Cicero AFG. Clinical applications of astaxanthin in the treatment of ocular diseases: emerging insights. Mar Drugs. 2020. https:\/\/doi.org\/10.3390\/md18050239.","journal-title":"Mar Drugs"},{"issue":"16","key":"3848_CR101","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s40265-015-0483-x","volume":"75","author":"GM Keating","year":"2015","unstructured":"Keating GM. Axitinib: a review in advanced renal cell carcinoma. Drugs. 2015;75(16):1903\u201313. https:\/\/doi.org\/10.1007\/s40265-015-0483-x.","journal-title":"Drugs"},{"key":"3848_CR102","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c04494","author":"W Chang","year":"2024","unstructured":"Chang W, Lv X, Zhu J, Shen JJ, Yao J, Liu Z, et al. Multifunctional nanotherapeutics with long-acting release against macular degeneration by minimally invasive administration. ACS Nano. 2024. https:\/\/doi.org\/10.1021\/acsnano.4c04494.","journal-title":"ACS Nano"},{"key":"3848_CR103","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.reth.2024.06.019","volume":"26","author":"JF Xu","year":"2024","unstructured":"Xu JF, Wang YP, Liu XH. Novel fabrication of anti-VEGF drug ranibizumab loaded PLGA\/PLA co-polymeric nanomicelles for long-acting intraocular delivery in the treatment of age-related macular degeneration therapy. Regen Ther. 2024;26:620\u201334. https:\/\/doi.org\/10.1016\/j.reth.2024.06.019.","journal-title":"Regen Ther"},{"key":"3848_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124758","volume":"666","author":"Q Chen","year":"2024","unstructured":"Chen Q, Qiu FS, Xie W, Yu WY, Su ZA, Qin GM, et al. Gypenoside A-loaded mPEG-PLGA nanoparticles ameliorate high-glucose-induced retinal microvasculopathy by inhibiting ferroptosis. Int J Pharm. 2024;666:124758. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124758.","journal-title":"Int J Pharm"},{"key":"3848_CR105","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbae124","volume":"11","author":"L Wang","year":"2024","unstructured":"Wang L, Jiang Y, Yao Y, Deng Y, Liu Z, Ding J, et al. Injectable drug-loaded thermosensitive hydrogel delivery system for protecting retina ganglion cells in traumatic optic neuropathy. Regen Biomater. 2024;11:rbae124. https:\/\/doi.org\/10.1093\/rb\/rbae124.","journal-title":"Regen Biomater"},{"key":"3848_CR106","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.actbio.2022.03.015","volume":"144","author":"SN Kim","year":"2022","unstructured":"Kim SN, Min CH, Kim YK, Ha A, Park CG, Lee SH, et al. Iontophoretic ocular delivery of latanoprost-loaded nanoparticles via skin-attached electrodes. Acta Biomater. 2022;144:32\u201341. https:\/\/doi.org\/10.1016\/j.actbio.2022.03.015.","journal-title":"Acta Biomater"},{"key":"3848_CR107","doi-asserted-by":"publisher","DOI":"10.1177\/2280800020942712","volume":"18","author":"J Song","year":"2020","unstructured":"Song J, Zhang Z. Brinzolamide loaded core-shell nanoparticles for enhanced coronial penetration in the treatment of glaucoma. J Appl Biomater Funct Mater. 2020;18:2280800020942712. https:\/\/doi.org\/10.1177\/2280800020942712.","journal-title":"J Appl Biomater Funct Mater"},{"issue":"7","key":"3848_CR108","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1208\/s12249-017-0710-8","volume":"18","author":"HA Salama","year":"2017","unstructured":"Salama HA, Ghorab M, Mahmoud AA, Abdel Hady M. PLGA nanoparticles as subconjunctival injection for management of glaucoma. AAPS PharmSciTech. 2017;18(7):2517\u201328. https:\/\/doi.org\/10.1208\/s12249-017-0710-8.","journal-title":"AAPS PharmSciTech"},{"key":"3848_CR109","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.colsurfb.2014.07.004","volume":"122","author":"MH Warsi","year":"2014","unstructured":"Warsi MH, Anwar M, Garg V, Jain GK, Talegaonkar S, Ahmad FJ, et al. Dorzolamide-loaded PLGA\/vitamin E TPGS nanoparticles for glaucoma therapy: pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits. Colloids Surf B Biointerfaces. 2014;122:423\u201331. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.07.004.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3848_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2025.107016","volume":"206","author":"CE Amankwa","year":"2025","unstructured":"Amankwa CE, DebNath B, Pham JH, Johnson GA, Zhang W, Ranjan A, et al. Optimized PLGA encapsulated SA-2 nanosuspension exhibits sustained intraocular pressure reduction in the mouse microbead occlusion model of ocular hypertension. Eur J Pharm Sci. 2025;206:107016. https:\/\/doi.org\/10.1016\/j.ejps.2025.107016.","journal-title":"Eur J Pharm Sci"},{"key":"3848_CR111","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01702-x","author":"A Arag\u00f3n-Navas","year":"2024","unstructured":"Arag\u00f3n-Navas A, Rodrigo MJ, Munuera I, Garc\u00eda-Herranz D, Sub\u00edas M, Villacampa P, et al. Multi-loaded PLGA microspheres as neuroretinal therapy in a chronic glaucoma animal model. Drug Delivery and Translational Research. 2024. https:\/\/doi.org\/10.1007\/s13346-024-01702-x.","journal-title":"Drug Delivery and Translational Research"},{"issue":"6","key":"3848_CR112","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/1061186x.2010.504268","volume":"19","author":"H Gupta","year":"2011","unstructured":"Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. J Drug Target. 2011;19(6):409\u201317. https:\/\/doi.org\/10.3109\/1061186x.2010.504268.","journal-title":"J Drug Target"},{"issue":"2","key":"3848_CR113","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.nano.2009.10.004","volume":"6","author":"H Gupta","year":"2010","unstructured":"Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine. 2010;6(2):324\u201333. https:\/\/doi.org\/10.1016\/j.nano.2009.10.004.","journal-title":"Nanomedicine"},{"issue":"1","key":"3848_CR114","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0014-4835(02)00247-6","volume":"76","author":"T Sarna","year":"2003","unstructured":"Sarna T, Burke JM, Korytowski W, R\u00f3zanowska M, Skumatz CM, Zareba A, et al. Loss of melanin from human RPE with aging: possible role of melanin photooxidation. Exp Eye Res. 2003;76(1):89\u201398. https:\/\/doi.org\/10.1016\/s0014-4835(02)00247-6.","journal-title":"Exp Eye Res"},{"issue":"11","key":"3848_CR115","doi-asserted-by":"publisher","first-page":"19412","DOI":"10.1021\/acsnano.2c09087","volume":"16","author":"YS Kwon","year":"2022","unstructured":"Kwon YS, Zheng M, Zhang AY, Han Z. Melanin-like nanoparticles as an alternative to natural melanin in retinal pigment epithelium cells and their therapeutic effects against age-related macular degeneration. ACS Nano. 2022;16(11):19412\u201322. https:\/\/doi.org\/10.1021\/acsnano.2c09087.","journal-title":"ACS Nano"},{"issue":"30","key":"3848_CR116","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401613","volume":"13","author":"K Huang","year":"2024","unstructured":"Huang K, Deng H, Wang S, Zhang F, Huang G, Wang L, et al. Melanin-like nanomedicine functions as a novel RPE ferroptosis inhibitor to ameliorate retinal degeneration and visual impairment in dry age-related macular degeneration. Adv Healthc Mater. 2024;13(30):e2401613. https:\/\/doi.org\/10.1002\/adhm.202401613.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"3848_CR117","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1021\/acs.biomac.8b00437","volume":"19","author":"L Huang","year":"2018","unstructured":"Huang L, Liu M, Huang H, Wen Y, Zhang X, Wei Y. Recent advances and progress on melanin-like materials and their biomedical applications. Biomacromolecules. 2018;19(6):1858\u201368. https:\/\/doi.org\/10.1021\/acs.biomac.8b00437.","journal-title":"Biomacromolecules"},{"issue":"18","key":"3848_CR118","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1039\/d0bm01070g","volume":"8","author":"J Hu","year":"2020","unstructured":"Hu J, Yang L, Yang P, Jiang S, Liu X, Li Y. Polydopamine free radical scavengers. Biomater Sci. 2020;8(18):4940\u201350. https:\/\/doi.org\/10.1039\/d0bm01070g.","journal-title":"Biomater Sci"},{"issue":"28","key":"3848_CR119","doi-asserted-by":"publisher","first-page":"15220","DOI":"10.1002\/anie.202101033","volume":"60","author":"Y Guo","year":"2021","unstructured":"Guo Y, Baschieri A, Mollica F, Valgimigli L, Cedrowski J, Litwinienko G, et al. Hydrogen atom transfer from HOO(.) to ortho-quinones explains the antioxidant activity of polydopamine. Angew Chem Int Ed Engl. 2021;60(28):15220\u20134. https:\/\/doi.org\/10.1002\/anie.202101033.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"24","key":"3848_CR120","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1039\/d2bm00905f","volume":"10","author":"MM Allyn","year":"2022","unstructured":"Allyn MM, Rincon-Benavides MA, Chandler HL, Higuita-Castro N, Palmer AF, Swindle-Reilly KE. Sustained release of heme-albumin as a potential novel therapeutic approach for age-related macular degeneration. Biomater Sci. 2022;10(24):7004\u201314. https:\/\/doi.org\/10.1039\/d2bm00905f.","journal-title":"Biomater Sci"},{"key":"3848_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860070","volume":"13","author":"NPB Au","year":"2022","unstructured":"Au NPB, Ma CHE. Neuroinflammation, microglia and implications for retinal ganglion cell survival and axon regeneration in traumatic optic neuropathy. Front Immunol. 2022;13:860070. https:\/\/doi.org\/10.3389\/fimmu.2022.860070.","journal-title":"Front Immunol"},{"issue":"1","key":"3848_CR122","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1186\/s12951-024-02962-y","volume":"22","author":"T Pan","year":"2024","unstructured":"Pan T, Huang Y, Wei J, Lai C, Chen Y, Nan K, et al. Implantation of biomimetic polydopamine nanocomposite scaffold promotes optic nerve regeneration through modulating inhibitory microenvironment. J Nanobiotechnol. 2024;22(1):683. https:\/\/doi.org\/10.1186\/s12951-024-02962-y.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3848_CR123","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12951-021-01199-3","volume":"19","author":"X Lou","year":"2021","unstructured":"Lou X, Hu Y, Zhang H, Liu J, Zhao Y. Polydopamine nanoparticles attenuate retina ganglion cell degeneration and restore visual function after optic nerve injury. J Nanobiotechnol. 2021;19(1):436. https:\/\/doi.org\/10.1186\/s12951-021-01199-3.","journal-title":"J Nanobiotechnol"},{"issue":"29","key":"3848_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400230","volume":"11","author":"YS Kwon","year":"2024","unstructured":"Kwon YS, Munsoor J, Kaufmann M, Zheng M, Smirnov AI, Han Z. Polydopamine nanoparticles as mimicking RPE melanin for the protection of retinal cells against blue light-induced phototoxicity. Adv Sci. 2024;11(29):e2400230. https:\/\/doi.org\/10.1002\/advs.202400230.","journal-title":"Adv Sci"},{"issue":"32","key":"3848_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402368","volume":"11","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhao C, Shi Z, Heger Z, Jing H, Shi Z, et al. A glucose-responsive hydrogel inhibits primary and secondary BRB injury for retinal microenvironment remodeling in diabetic retinopathy. Adv Sci. 2024;11(32):e2402368. https:\/\/doi.org\/10.1002\/advs.202402368.","journal-title":"Adv Sci"},{"issue":"1","key":"3848_CR126","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12951-021-00939-9","volume":"19","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhu J, Zhao L, Mao K, Gu Q, Li D, et al. RGD-modified multifunctional nanoparticles encapsulating Salvianolic acid A for targeted treatment of choroidal neovascularization. J Nanobiotechnol. 2021;19(1):196. https:\/\/doi.org\/10.1186\/s12951-021-00939-9.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"3848_CR127","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1089\/jop.2019.0148","volume":"36","author":"W Zhang","year":"2020","unstructured":"Zhang W, Kantaria T, Zhang Y, Kantaria T, Kobauri S, Tugushi D, et al. Biodegradable nanoparticles based on pseudo-proteins show promise as carriers for ophthalmic drug delivery. J Ocul Pharmacol Ther. 2020;36(6):421\u201332. https:\/\/doi.org\/10.1089\/jop.2019.0148.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"8","key":"3848_CR128","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3109\/03639045.2012.704381","volume":"39","author":"K Yadav","year":"2013","unstructured":"Yadav K, Yadav D, Srivastava AK. Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of Venlafaxine hydrochloride. Drug Dev Ind Pharm. 2013;39(8):1197\u2013206. https:\/\/doi.org\/10.3109\/03639045.2012.704381.","journal-title":"Drug Dev Ind Pharm"},{"issue":"9","key":"3848_CR129","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1049\/iet-nbt.2019.0002","volume":"13","author":"SP Chegini","year":"2019","unstructured":"Chegini SP, Varshosaz J, Sadeghi HM, Dehghani A, Minayian M. Poly(glycerol sebacate) nanoparticles for ocular delivery of sunitinib: physicochemical, cytotoxic and allergic studies. IET Nanobiotechnol. 2019;13(9):974\u201382. https:\/\/doi.org\/10.1049\/iet-nbt.2019.0002.","journal-title":"IET Nanobiotechnol"},{"key":"3848_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041096","author":"P Colucci","year":"2023","unstructured":"Colucci P, Giannaccini M, Baggiani M, Kennedy BN, Dente L, Raffa V, et al. Neuroprotective nanoparticles targeting the retina: a polymeric platform for ocular drug delivery applications. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15041096.","journal-title":"Pharmaceutics"},{"key":"3848_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121045","volume":"608","author":"DA Srinivasarao","year":"2021","unstructured":"Srinivasarao DA, Sreenivasa Reddy S, Bhanuprakash Reddy G, Katti DS. Simultaneous amelioration of diabetic ocular complications in lens and retinal tissues using a non-invasive drug delivery system. Int J Pharm. 2021;608:121045. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121045.","journal-title":"Int J Pharm"},{"issue":"7","key":"3848_CR132","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/aos.15101","volume":"100","author":"L Lorenzo-Soler","year":"2022","unstructured":"Lorenzo-Soler L, Praphanwittaya P, Olafsdottir OB, Kristinsdottir IM, Asgrimsdottir GM, Loftsson T, et al. Topical noninvasive retinal drug delivery of a tyrosine kinase inhibitor: 3% cediranib maleate cyclodextrin nanoparticle eye drops in the rabbit eye. Acta Ophthalmol. 2022;100(7):788\u201396. https:\/\/doi.org\/10.1111\/aos.15101.","journal-title":"Acta Ophthalmol"},{"key":"3848_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/ijn.S93069","volume":"11","author":"M Kalomiraki","year":"2016","unstructured":"Kalomiraki M, Thermos K, Chaniotakis NA. Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications. Int J Nanomed. 2016;11:1\u201312. https:\/\/doi.org\/10.2147\/ijn.S93069.","journal-title":"Int J Nanomed"},{"key":"3848_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071444","author":"RA Alshammari","year":"2022","unstructured":"Alshammari RA, Aleanizy FS, Aldarwesh A, Alqahtani FY, Mahdi WA, Alquadeib B, et al. Retinal delivery of the protein kinase C-\u03b2 inhibitor ruboxistaurin using non-invasive nanoparticles of polyamidoamine dendrimers. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14071444.","journal-title":"Pharmaceutics"},{"issue":"4","key":"3848_CR135","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1021\/acsabm.0c00080","volume":"3","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Yu Y, Li G, Meng H, Zhang X, Dong L, et al. A bioadhesive nanoplatform enhances the permeation of drugs used to treat diabetic macular edema. ACS Appl Bio Mater. 2020;3(4):2314\u201324. https:\/\/doi.org\/10.1021\/acsabm.0c00080.","journal-title":"ACS Appl Bio Mater"},{"issue":"14","key":"3848_CR136","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.2217\/nnm-2019-0040","volume":"14","author":"ARN Pontillo","year":"2019","unstructured":"Pontillo ARN, Detsi A. Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier. Nanomed Lond. 2019;14(14):1889\u2013909. https:\/\/doi.org\/10.2217\/nnm-2019-0040.","journal-title":"Nanomed Lond"},{"issue":"11","key":"3848_CR137","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1211\/0022357022476","volume":"55","author":"MJ Alonso","year":"2003","unstructured":"Alonso MJ, S\u00e1nchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol. 2003;55(11):1451\u201363. https:\/\/doi.org\/10.1211\/0022357022476.","journal-title":"J Pharm Pharmacol"},{"key":"3848_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118943","volume":"575","author":"A Yu","year":"2020","unstructured":"Yu A, Shi H, Liu H, Bao Z, Dai M, Lin D, et al. Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery. Int J Pharm. 2020;575:118943. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118943.","journal-title":"Int J Pharm"},{"key":"3848_CR139","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.ijbiomac.2022.09.101","volume":"220","author":"SL Taheri","year":"2022","unstructured":"Taheri SL, Rezazadeh M, Hassanzadeh F, Akbari V, Dehghani A, Talebi A, et al. Preparation, physicochemical, and retinal anti-angiogenic evaluation of poloxamer hydrogel containing dexamethasone\/avastin-loaded chitosan-N-acetyl-L-cysteine nanoparticles. Int J Biol Macromol. 2022;220:1605\u201318. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.09.101.","journal-title":"Int J Biol Macromol"},{"key":"3848_CR140","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijbiomac.2015.11.070","volume":"84","author":"SB da Silva","year":"2016","unstructured":"da Silva SB, Ferreira D, Pintado M, Sarmento B. Chitosan-based nanoparticles for rosmarinic acid ocular delivery\u2013in vitro tests. Int J Biol Macromol. 2016;84:112\u201320. https:\/\/doi.org\/10.1016\/j.ijbiomac.2015.11.070.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"3848_CR141","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1208\/s12249-013-9943-3","volume":"14","author":"Y Wang","year":"2013","unstructured":"Wang Y, Li P, Kong L. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery. AAPS PharmSciTech. 2013;14(2):585\u201392. https:\/\/doi.org\/10.1208\/s12249-013-9943-3.","journal-title":"AAPS PharmSciTech"},{"key":"3848_CR142","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/ijn.S184574","volume":"14","author":"X Rong","year":"2019","unstructured":"Rong X, Ji Y, Zhu X, Yang J, Qian D, Mo X, et al. Neuroprotective effect of insulin-loaded Chitosan nanoparticles\/PLGA-PEG-PLGA hydrogel on diabetic retinopathy in rats. Int J Nanomed. 2019;14:45\u201355. https:\/\/doi.org\/10.2147\/ijn.S184574.","journal-title":"Int J Nanomed"},{"key":"3848_CR143","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jddst.2018.12.032","volume":"49","author":"X Rong","year":"2019","unstructured":"Rong X, Yang J, Ji Y, Zhu X, Lu Y, Mo X. Biocompatibility and safety of insulin-loaded Chitosan nanoparticles\/ PLGA-PEG-PLGA hydrogel (ICNPH) delivered by subconjunctival injection in rats. J Drug Deliv Sci Technol. 2019;49:556\u201362. https:\/\/doi.org\/10.1016\/j.jddst.2018.12.032.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3848_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101590","author":"M Dandamudi","year":"2021","unstructured":"Dandamudi M, McLoughlin P, Behl G, Rani S, Coffey L, Chauhan A, et al. Chitosan-coated PLGA nanoparticles encapsulating triamcinolone acetonide as a potential candidate for sustained ocular drug delivery. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13101590.","journal-title":"Pharmaceutics"},{"issue":"7","key":"3848_CR145","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/21691401.2016.1243545","volume":"45","author":"J Pandit","year":"2017","unstructured":"Pandit J, Sultana Y, Aqil M. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation. Artif Cells Nanomed Biotechnol. 2017;45(7):1397\u2013407. https:\/\/doi.org\/10.1080\/21691401.2016.1243545.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"4","key":"3848_CR146","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/jamaophthalmol.2018.6399","volume":"137","author":"EY Kang","year":"2019","unstructured":"Kang EY, Chen TH, Garg SJ, Sun CC, Kang JH, Wu WC, et al. Association of statin therapy with prevention of vision-threatening diabetic retinopathy. JAMA Ophthalmol. 2019;137(4):363\u201371. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.6399.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"3848_CR147","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41598-017-02407-7","volume":"7","author":"B Tian","year":"2017","unstructured":"Tian B, Al-Moujahed A, Bouzika P, Hu Y, Notomi S, Tsoka P, et al. Atorvastatin promotes phagocytosis and attenuates pro-inflammatory response in human retinal pigment epithelial cells. Sci Rep. 2017;7(1):2329. https:\/\/doi.org\/10.1038\/s41598-017-02407-7.","journal-title":"Sci Rep"},{"issue":"4","key":"3848_CR148","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s13346-020-00733-4","volume":"10","author":"M Yadav","year":"2020","unstructured":"Yadav M, Schiavone N, Guzman-Aranguez A, Giansanti F, Papucci L, de Perez Lara MJ, et al. Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD). Drug Deliv Transl Res. 2020;10(4):919\u201344. https:\/\/doi.org\/10.1007\/s13346-020-00733-4.","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"3848_CR149","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/bjo.2004.050401","volume":"89","author":"PB Thomas","year":"2005","unstructured":"Thomas PB, Albini T, Giri RK, See RF, Evans M, Rao NA. The effects of atorvastatin in experimental autoimmune uveitis. Br J Ophthalmol. 2005;89(3):275\u20139. https:\/\/doi.org\/10.1136\/bjo.2004.050401.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"3848_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80127-1","volume":"11","author":"Y Mysore","year":"2021","unstructured":"Mysore Y, Del Amo EM, Loukovaara S, Hagstr\u00f6m M, Urtti A, Kauppinen A. Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous. Sci Rep. 2021;11(1):980. https:\/\/doi.org\/10.1038\/s41598-020-80127-1.","journal-title":"Sci Rep"},{"key":"3848_CR151","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2147\/ijn.S237314","volume":"15","author":"MG Arafa","year":"2020","unstructured":"Arafa MG, Girgis GNS, El-Dahan MS. Chitosan-coated PLGA nanoparticles for enhanced ocular anti-inflammatory efficacy of atorvastatin calcium. Int J Nanomedicine. 2020;15:1335\u201347. https:\/\/doi.org\/10.2147\/ijn.S237314.","journal-title":"Int J Nanomedicine"},{"key":"3848_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071479","author":"S Casey-Power","year":"2022","unstructured":"Casey-Power S, Ryan R, Behl G, McLoughlin P, Byrne ME, Fitzhenry L. Hyaluronic acid: its versatile use in ocular drug delivery with a specific focus on hyaluronic acid-based polyelectrolyte complexes. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14071479.","journal-title":"Pharmaceutics"},{"issue":"7","key":"3848_CR153","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1016\/j.actbio.2013.03.005","volume":"9","author":"A Fakhari","year":"2013","unstructured":"Fakhari A, Berkland C. Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment. Acta Biomater. 2013;9(7):7081\u201392. https:\/\/doi.org\/10.1016\/j.actbio.2013.03.005.","journal-title":"Acta Biomater"},{"key":"3848_CR154","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/563818","volume":"2015","author":"JM Cyphert","year":"2015","unstructured":"Cyphert JM, Trempus CS, Garantziotis S. Size matters: molecular weight specificity of hyaluronan effects in cell biology. Int J Cell Biol. 2015;2015:563818. https:\/\/doi.org\/10.1155\/2015\/563818.","journal-title":"Int J Cell Biol"},{"issue":"6","key":"3848_CR155","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.8.6.2","volume":"8","author":"P Aragona","year":"2019","unstructured":"Aragona P, Simmons PA, Wang H, Wang T. Physicochemical properties of hyaluronic acid-based lubricant eye drops. Trans Vis Sci Technol. 2019;8(6):2. https:\/\/doi.org\/10.1167\/tvst.8.6.2.","journal-title":"Trans Vis Sci Technol"},{"key":"3848_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmbbm.2023.105908","volume":"143","author":"C Guarise","year":"2023","unstructured":"Guarise C, Acquasaliente L, Pasut G, Pavan M, Soato M, Garofolin G, et al. The role of high molecular weight hyaluronic acid in mucoadhesion on an ocular surface model. J Mech Behav Biomed Mater. 2023;143:105908. https:\/\/doi.org\/10.1016\/j.jmbbm.2023.105908.","journal-title":"J Mech Behav Biomed Mater"},{"key":"3848_CR157","doi-asserted-by":"publisher","first-page":"622","DOI":"10.12688\/f1000research.6885.1","volume":"4","author":"MK Cowman","year":"2015","unstructured":"Cowman MK, Schmidt TA, Raghavan P, Stecco A. Viscoelastic properties of hyaluronan in physiological conditions. F1000Res. 2015;4:622. https:\/\/doi.org\/10.12688\/f1000research.6885.1.","journal-title":"F1000Res"},{"key":"3848_CR158","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.2147\/ijn.S316564","volume":"16","author":"SE Radwan","year":"2021","unstructured":"Radwan SE, El-Kamel A, Zaki EI, Burgalassi S, Zucchetti E, El-Moslemany RM. Hyaluronic-coated albumin nanoparticles for the non-invasive delivery of apatinib in diabetic retinopathy. Int J Nanomed. 2021;16:4481\u201394. https:\/\/doi.org\/10.2147\/ijn.S316564.","journal-title":"Int J Nanomed"},{"issue":"6","key":"3848_CR159","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/j.1471-4159.2010.07072.x","volume":"115","author":"T Shinoe","year":"2010","unstructured":"Shinoe T, Kuribayashi H, Saya H, Seiki M, Aburatani H, Watanabe S. Identification of CD44 as a cell surface marker for M\u00fcller glia precursor cells. J Neurochem. 2010;115(6):1633\u201342. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07072.x.","journal-title":"J Neurochem"},{"issue":"4","key":"3848_CR160","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00417-012-2103-8","volume":"251","author":"TJ Chipps","year":"2013","unstructured":"Chipps TJ, Appukuttan B, Pan Y, Smith JR. CD44 isoforms in human retinal and choroidal endothelial cells. Graefes Arch Clin Exp Ophthalmol. 2013;251(4):1245\u20136. https:\/\/doi.org\/10.1007\/s00417-012-2103-8.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"3848_CR161","first-page":"2027","volume":"38","author":"NP Liu","year":"1997","unstructured":"Liu NP, Roberts WL, Hale LP, Levesque MC, Patel DD, Lu CL, et al. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1997;38(10):2027\u201337.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3848_CR162","first-page":"223","volume":"38","author":"H Kuhrt","year":"1997","unstructured":"Kuhrt H, H\u00e4rtig W, Grimm D, Faude F, Kasper M, Reichenbach A. Changes in CD44 and ApoE immunoreactivities due to retinal pathology of man and rat. J Hirnforsch. 1997;38(2):223\u20139.","journal-title":"J Hirnforsch"},{"issue":"1","key":"3848_CR163","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12951-024-03082-3","volume":"23","author":"W Tang","year":"2025","unstructured":"Tang W, Huang X, Yi YD, Cao F, Deng M, Fan J, et al. Hyaluronic acid-curcumin nanoparticles for preventing the progression of experimental autoimmune uveitis through the Keap1\/Nrf2\/HO-1 signaling pathway. J Nanobiotechnol. 2025;23(1):89. https:\/\/doi.org\/10.1186\/s12951-024-03082-3.","journal-title":"J Nanobiotechnol"},{"issue":"45","key":"3848_CR164","doi-asserted-by":"publisher","first-page":"34601","DOI":"10.1074\/jbc.M601530200","volume":"281","author":"SP Thankamony","year":"2006","unstructured":"Thankamony SP, Knudson W. Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis. J Biol Chem. 2006;281(45):34601\u20139. https:\/\/doi.org\/10.1074\/jbc.M601530200.","journal-title":"J Biol Chem"},{"key":"3848_CR165","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.matbio.2016.12.001","volume":"60\u201361","author":"TN Wight","year":"2017","unstructured":"Wight TN. Provisional matrix: a role for versican and hyaluronan. Matrix Biol. 2017;60\u201361:38\u201356. https:\/\/doi.org\/10.1016\/j.matbio.2016.12.001.","journal-title":"Matrix Biol"},{"key":"3848_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2019.100642","volume":"18","author":"C Chandola","year":"2019","unstructured":"Chandola C, Casteleijn MG, Chandola UM, Gopalan LN, Urtti A, Neerathilingam M. CD44 aptamer mediated cargo delivery to lysosomes of retinal pigment epithelial cells to prevent age-related macular degeneration. Biochem Biophys Rep. 2019;18:100642. https:\/\/doi.org\/10.1016\/j.bbrep.2019.100642.","journal-title":"Biochem Biophys Rep"},{"issue":"9","key":"3848_CR167","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1167\/iovs.08-3044","volume":"50","author":"H Mochimaru","year":"2009","unstructured":"Mochimaru H, Takahashi E, Tsukamoto N, Miyazaki J, Yaguchi T, Koto T, et al. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Invest Ophthalmol Vis Sci. 2009;50(9):4410\u20135. https:\/\/doi.org\/10.1167\/iovs.08-3044.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3848_CR168","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12974-024-03175-8","volume":"21","author":"M Ayten","year":"2024","unstructured":"Ayten M, Straub T, Kaplan L, Hauck SM, Grosche A, Koch SF. CD44 signaling in M\u00fcller cells impacts photoreceptor function and survival in healthy and diseased retinas. J Neuroinflammation. 2024;21(1):190. https:\/\/doi.org\/10.1186\/s12974-024-03175-8.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"3848_CR169","doi-asserted-by":"publisher","first-page":"106839","DOI":"10.1016\/j.isci.2023.106839","volume":"26","author":"H Yu","year":"2023","unstructured":"Yu H, Zhong H, Sun J, Li N, Chen J, Shen B, et al. Molecular signaling from microglia impacts macroglia autophagy and neurons survival in glaucoma. iScience. 2023;26(6):106839. https:\/\/doi.org\/10.1016\/j.isci.2023.106839.","journal-title":"iScience"},{"key":"3848_CR170","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejpb.2017.06.009","volume":"119","author":"D Huang","year":"2017","unstructured":"Huang D, Chen YS, Thakur SS, Rupenthal ID. Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection. Eur J Pharm Biopharm. 2017;119:125\u201336. https:\/\/doi.org\/10.1016\/j.ejpb.2017.06.009.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"3848_CR171","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1021\/acs.molpharmaceut.6b01029","volume":"14","author":"D Huang","year":"2017","unstructured":"Huang D, Chen YS, Rupenthal ID. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery to the retina. Mol Pharm. 2017;14(2):533\u201345. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b01029.","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"3848_CR172","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijpharm.2018.02.003","volume":"541","author":"I de Luis Red\u00edn","year":"2018","unstructured":"de Luis Red\u00edn I, Boiero C, Mart\u00ednez-Oh\u00e1rriz MC, Ag\u00fceros M, Ramos R, Pe\u00f1uelas I, et al. Human serum albumin nanoparticles for ocular delivery of bevacizumab. Int J Pharm. 2018;541(1\u20132):214\u201323. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.02.003.","journal-title":"Int J Pharm"},{"issue":"6","key":"3848_CR173","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.exer.2006.10.018","volume":"84","author":"PO Lundmark","year":"2007","unstructured":"Lundmark PO, Pandi-Perumal SR, Srinivasan V, Cardinali DP, Rosenstein RE. Melatonin in the eye: implications for glaucoma. Exp Eye Res. 2007;84(6):1021\u201330. https:\/\/doi.org\/10.1016\/j.exer.2006.10.018.","journal-title":"Exp Eye Res"},{"key":"3848_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122308","volume":"628","author":"S Mickaela Martinez","year":"2022","unstructured":"Mickaela Martinez S, Inda A, Marina Garcia A, Mar\u00eda Berm\u00fadez J, Emilio Gonzo E, Herrero-Vanrell R, et al. Development of melatonin-loaded, human-serum-albumin nanoparticles formulations using different methods of preparation for ophthalmic administration. Int J Pharm. 2022;628:122308. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122308.","journal-title":"Int J Pharm"},{"key":"3848_CR175","doi-asserted-by":"publisher","first-page":"123653","DOI":"10.1016\/j.ijpharm.2023.123653","volume":"649","author":"A Arag\u00f3n-Navas","year":"2024","unstructured":"Arag\u00f3n-Navas A, L\u00f3pez-Cano JJ, Johnson M, Vicario-de-la-Torre AS, Andr\u00e9s-Guerrero M. Smart biodegradable hydrogels: Drug-delivery platforms for treatment of chronic ophthalmic diseases affecting the back of the eye. Int J Pharm. 2024;649:123653. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123653.","journal-title":"Int J Pharm"},{"key":"3848_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010025","author":"I Ottonelli","year":"2022","unstructured":"Ottonelli I, Bighinati A, Adani E, Loll F, Caraffi R, Vandelli MA, et al. Optimization of an injectable hydrogel depot system for the controlled release of retinal-targeted hybrid nanoparticles. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics15010025.","journal-title":"Pharmaceutics"},{"key":"3848_CR177","doi-asserted-by":"publisher","DOI":"10.3390\/ph16020164","author":"B Silva","year":"2023","unstructured":"Silva B, Gon\u00e7alves LM, Braz BS, Delgado E. Topical administration of a nanoformulation of chitosan-hyaluronic acid-epoetin beta in a rat model of glaucoma. Pharmaceuticals (Basel). 2023. https:\/\/doi.org\/10.3390\/ph16020164.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3848_CR178","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27041372","author":"P Liu","year":"2022","unstructured":"Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27041372.","journal-title":"Molecules"},{"issue":"5","key":"3848_CR179","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8(5):e09394. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394.","journal-title":"Heliyon"},{"key":"3848_CR180","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030543","author":"D Lombardo","year":"2022","unstructured":"Lombardo D, Kiselev MA. Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14030543.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3848_CR181","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/jop.2012.0128","volume":"29","author":"A del Pozo-Rodr\u00edguez","year":"2013","unstructured":"del Pozo-Rodr\u00edguez A, Delgado D, Gasc\u00f3n AR, Solin\u00eds M. Lipid nanoparticles as drug\/gene delivery systems to the retina. J Ocul Pharmacol Ther. 2013;29(2):173\u201388. https:\/\/doi.org\/10.1089\/jop.2012.0128.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3848_CR182","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061593","author":"C Viegas","year":"2023","unstructured":"Viegas C, Patr\u00edcio AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15061593.","journal-title":"Pharmaceutics"},{"key":"3848_CR183","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.783831","volume":"8","author":"H Lu","year":"2021","unstructured":"Lu H, Zhang S, Wang J, Chen Q. A review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems. Front Nutr. 2021;8:783831. https:\/\/doi.org\/10.3389\/fnut.2021.783831.","journal-title":"Front Nutr"},{"issue":"1","key":"3848_CR184","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12951-019-0498-7","volume":"17","author":"S Lai","year":"2019","unstructured":"Lai S, Wei Y, Wu Q, Zhou K, Liu T, Zhang Y, et al. Liposomes for effective drug delivery to the ocular posterior chamber. J Nanobiotechnol. 2019;17(1):64. https:\/\/doi.org\/10.1186\/s12951-019-0498-7.","journal-title":"J Nanobiotechnol"},{"key":"3848_CR185","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.2147\/ijn.S452134","volume":"19","author":"E Esposito","year":"2024","unstructured":"Esposito E, Pozza E, Contado C, Pula W, Bortolini O, Ragno D, et al. Microfluidic fabricated liposomes for Nutlin-3a ocular delivery as potential candidate for proliferative vitreoretinal diseases treatment. Int J Nanomed. 2024;19:3513\u201336. https:\/\/doi.org\/10.2147\/ijn.S452134.","journal-title":"Int J Nanomed"},{"issue":"1","key":"3848_CR186","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12951-024-02943-1","volume":"22","author":"M Zhang","year":"2024","unstructured":"Zhang M, Lu X, Luo L, Dou J, Zhang J, Li G, et al. Targeting glutamine synthetase with AS1411-modified exosome-liposome hybrid nanoparticles for inhibition of choroidal neovascularization. J Nanobiotechnol. 2024;22(1):703. https:\/\/doi.org\/10.1186\/s12951-024-02943-1.","journal-title":"J Nanobiotechnol"},{"key":"3848_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124700","volume":"665","author":"E Zingale","year":"2024","unstructured":"Zingale E, Weaver E, Bertelli PM, Lengyel I, Pignatello R, Lamprou DA. Development of dual drug loaded-hydrogel scaffold combining microfluidics and coaxial 3D-printing for intravitreal implantation. Int J Pharm. 2024;665:124700. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124700.","journal-title":"Int J Pharm"},{"key":"3848_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126480","volume":"252","author":"H Gu","year":"2023","unstructured":"Gu H, Chen P, Liu X, Lian Y, Xi J, Li J, et al. Trimethylated chitosan-coated flexible liposomes with resveratrol for topical drug delivery to reduce blue-light-induced retinal damage. Int J Biol Macromol. 2023;252:126480. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126480.","journal-title":"Int J Biol Macromol"},{"key":"3848_CR189","doi-asserted-by":"publisher","first-page":"7915","DOI":"10.2147\/ijn.S520756","volume":"20","author":"J Zhou","year":"2025","unstructured":"Zhou J, Zhao D, Niu S, Meng W, Chen Z, Li H, et al. RGD-Functionalized ginsenoside Rg3 liposomes for alleviating oxidative stress and choroidal neovascularization in Age-Related macular degeneration. Int J Nanomed. 2025;20:7915\u201333. https:\/\/doi.org\/10.2147\/ijn.S520756.","journal-title":"Int J Nanomed"},{"issue":"2","key":"3848_CR190","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ajpath.2012.04.018","volume":"181","author":"NG Kolosova","year":"2012","unstructured":"Kolosova NG, Muraleva NA, Zhdankina AA, Stefanova NA, Fursova AZ, Blagosklonny MV. Prevention of age-related macular degeneration-like retinopathy by rapamycin in rats. Am J Pathol. 2012;181(2):472\u20137. https:\/\/doi.org\/10.1016\/j.ajpath.2012.04.018.","journal-title":"Am J Pathol"},{"key":"3848_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2022.102571","volume":"44","author":"L Mei","year":"2022","unstructured":"Mei L, Yu M, Liu Y, Weh E, Pawar M, Li L, et al. Synthetic high-density lipoprotein nanoparticles delivering rapamycin for the treatment of age-related macular degeneration. Nanomedicine. 2022;44:102571. https:\/\/doi.org\/10.1016\/j.nano.2022.102571.","journal-title":"Nanomedicine"},{"key":"3848_CR192","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1475-2840-12-59","volume":"12","author":"C Berndt-Zipfel","year":"2013","unstructured":"Berndt-Zipfel C, Michelson G, Dworak M, Mitry M, L\u00f6ffler A, Pf\u00fctzner A, et al. Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study. Cardiovasc Diabetol. 2013;12:59. https:\/\/doi.org\/10.1186\/1475-2840-12-59.","journal-title":"Cardiovasc Diabetol"},{"key":"3848_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2024.100232","volume":"7","author":"AEH Ramadan","year":"2024","unstructured":"Ramadan AEH, Elsayed MMA, Elsayed A, Fouad MA, Mohamed MS, Lee S, et al. Development and optimization of vildagliptin solid lipid nanoparticles loaded ocuserts for controlled ocular delivery: a promising approach towards treating diabetic retinopathy. International Journal of Pharmaceutics: X. 2024;7:100232. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100232.","journal-title":"International Journal of Pharmaceutics: X"},{"key":"3848_CR194","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2024.1449380","volume":"12","author":"HI Mokhtar","year":"2024","unstructured":"Mokhtar HI, Khodeer DM, Alzahrani S, Qushawy M, Alshaman R, Elsherbiny NM, et al. Formulation and characterization of cholesterol-based nanoparticles of gabapentin protecting from retinal injury. Front Chem. 2024;12:1449380. https:\/\/doi.org\/10.3389\/fchem.2024.1449380.","journal-title":"Front Chem"},{"key":"3848_CR195","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ijbiomac.2020.04.115","volume":"156","author":"J Li","year":"2020","unstructured":"Li J, Jin X, Yang Y, Zhang L, Liu R, Li Z. Trimethyl chitosan nanoparticles for ocular Baicalein delivery: preparation, optimization, in vitro evaluation, in vivo pharmacokinetic study and molecular dynamics simulation. Int J Biol Macromol. 2020;156:749\u201361. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.04.115.","journal-title":"Int J Biol Macromol"},{"key":"3848_CR196","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejpb.2016.10.013","volume":"110","author":"E S\u00e1nchez-L\u00f3pez","year":"2017","unstructured":"S\u00e1nchez-L\u00f3pez E, Espina M, Doktorovova S, Souto EB, Garc\u00eda ML. Lipid nanoparticles (SLN, NLC): overcoming the anatomical and physiological barriers of the eye - Part II - ocular drug-loaded lipid nanoparticles. Eur J Pharm Biopharm. 2017;110:58\u201369. https:\/\/doi.org\/10.1016\/j.ejpb.2016.10.013.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3848_CR197","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40199-023-00455-1","volume":"31","author":"C Chapa Gonz\u00e1lez","year":"2023","unstructured":"Chapa Gonz\u00e1lez C, Mart\u00ednez Sar\u00e1oz JV, Roacho P\u00e9rez JA, Olivas Armend\u00e1riz I. Lipid nanoparticles for gene therapy in ocular diseases. DARU J Pharm Sci. 2023;31(1):75\u201382. https:\/\/doi.org\/10.1007\/s40199-023-00455-1.","journal-title":"DARU J Pharm Sci"},{"issue":"37","key":"3848_CR198","doi-asserted-by":"publisher","first-page":"e2400815","DOI":"10.1002\/smll.202400815","volume":"20","author":"Y Eygeris","year":"2024","unstructured":"Eygeris Y, Henderson MI, Curtis AG, Jozi\u0107 A, Stoddard J, Reynaga R, et al. Preformed vesicle approach to LNP manufacturing enhances retinal mRNA delivery. Small. 2024;20(37):e2400815. https:\/\/doi.org\/10.1002\/smll.202400815.","journal-title":"Small"},{"issue":"7","key":"3848_CR199","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.13.7.7","volume":"13","author":"CZ Chambers","year":"2024","unstructured":"Chambers CZ, Soo GL, Engel AL, Glass IA, Frassetto A, Martini PGV, et al. Lipid nanoparticle-mediated delivery of mRNA into the mouse and human retina and other ocular tissues. Transl Vis Sci Technol. 2024;13(7):7. https:\/\/doi.org\/10.1167\/tvst.13.7.7.","journal-title":"Transl Vis Sci Technol"},{"issue":"10","key":"3848_CR200","doi-asserted-by":"publisher","first-page":"e0241006","DOI":"10.1371\/journal.pone.0241006","volume":"15","author":"RC Ryals","year":"2020","unstructured":"Ryals RC, Patel S, Acosta C, McKinney M, Pennesi ME, Sahay G. The effects of pegylation on LNP based mRNA delivery to the eye. PLoS One. 2020;15(10):e0241006. https:\/\/doi.org\/10.1371\/journal.pone.0241006.","journal-title":"PLoS One"},{"key":"3848_CR201","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jconrel.2023.01.080","volume":"355","author":"W Li","year":"2023","unstructured":"Li W, Chen L, Gu Z, Chen Z, Li H, Cheng Z, et al. Co-delivery of microRNA-150 and quercetin by lipid nanoparticles (LNPs) for the targeted treatment of age-related macular degeneration (AMD). J Control Release. 2023;355:358\u201370. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.080.","journal-title":"J Control Release"},{"issue":"8","key":"3848_CR202","doi-asserted-by":"publisher","first-page":"e0306640","DOI":"10.1371\/journal.pone.0306640","volume":"19","author":"RT Carter","year":"2024","unstructured":"Carter RT, Swetledge S, Navarro S, Liu CC, Ineck N, Lewin AC, et al. The impact of lutein-loaded poly(lactic-co-glycolic acid) nanoparticles following topical application: an in vitro and in vivo study. PLoS One. 2024;19(8):e0306640. https:\/\/doi.org\/10.1371\/journal.pone.0306640.","journal-title":"PLoS One"},{"key":"3848_CR203","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.colsurfb.2015.10.026","volume":"136","author":"A Parra","year":"2015","unstructured":"Parra A, Mallandrich M, Clares B, Egea MA, Espina M, Garc\u00eda ML, et al. Design and elaboration of freeze-dried PLGA nanoparticles for the transcorneal permeation of carprofen: ocular anti-inflammatory applications. Colloids Surf B Biointerfaces. 2015;136:935\u201343. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.10.026.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3848_CR204","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29030658","author":"Z Qin","year":"2024","unstructured":"Qin Z, Li B, Deng Q, Wen Y, Feng S, Duan C, et al. Polymer nanoparticles with 2-HP-\u03b2-cyclodextrin for enhanced retention of uptake into HCE-T cells. Molecules. 2024. https:\/\/doi.org\/10.3390\/molecules29030658.","journal-title":"Molecules"},{"issue":"8","key":"3848_CR205","doi-asserted-by":"publisher","first-page":"e04589","DOI":"10.1016\/j.heliyon.2020.e04589","volume":"6","author":"UD Laddha","year":"2020","unstructured":"Laddha UD, Kshirsagar SJ. Formulation of PPAR-gamma agonist as surface modified PLGA nanoparticles for non-invasive treatment of diabetic retinopathy: in vitro and in vivo evidences. Heliyon. 2020;6(8):e04589. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04589.","journal-title":"Heliyon"},{"issue":"5","key":"3848_CR206","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1021\/acs.molpharmaceut.8b01319","volume":"16","author":"F Qiu","year":"2019","unstructured":"Qiu F, Meng T, Chen Q, Zhou K, Shao Y, Matlock G, et al. Fenofibrate-loaded biodegradable nanoparticles for the treatment of experimental diabetic retinopathy and neovascular age-related macular degeneration. Mol Pharm. 2019;16(5):1958\u201370. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b01319.","journal-title":"Mol Pharm"},{"issue":"9","key":"3848_CR207","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1021\/acs.molpharmaceut.6b00335","volume":"13","author":"N Elsaid","year":"2016","unstructured":"Elsaid N, Jackson TL, Elsaid Z, Alqathama A, Somavarapu S. PLGA microparticles entrapping chitosan-based nanoparticles for the ocular delivery of Ranibizumab. Mol Pharm. 2016;13(9):2923\u201340. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00335.","journal-title":"Mol Pharm"},{"key":"3848_CR208","doi-asserted-by":"publisher","first-page":"8819","DOI":"10.2147\/ijn.S217038","volume":"14","author":"J Liu","year":"2019","unstructured":"Liu J, Zhang X, Li G, Xu F, Li S, Teng L, et al. Anti-Angiogenic activity of Bevacizumab-Bearing Dexamethasone-Loaded PLGA nanoparticles for potential intravitreal applications. Int J Nanomed. 2019;14:8819\u201334. https:\/\/doi.org\/10.2147\/ijn.S217038.","journal-title":"Int J Nanomed"},{"issue":"4","key":"3848_CR209","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/adt.2019.920","volume":"17","author":"P Narvekar","year":"2019","unstructured":"Narvekar P, Bhatt P, Fnu G, Sutariya V. Axitinib-loaded poly(lactic-co-glycolic acid) nanoparticles for age-related macular degeneration: formulation development and in vitro characterization. Assay Drug Dev Technol. 2019;17(4):167\u201377. https:\/\/doi.org\/10.1089\/adt.2019.920.","journal-title":"Assay Drug Dev Technol"},{"issue":"8","key":"3848_CR210","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1167\/iovs.17-22829","volume":"59","author":"N Mat Nor","year":"2018","unstructured":"Mat Nor N, Guo CX, Rupenthal ID, Chen YS, Green CR, Acosta ML. Sustained Connexin43 mimetic peptide release from loaded nanoparticles reduces retinal and choroidal photodamage. Invest Ophthalmol Vis Sci. 2018;59(8):3682\u201393. https:\/\/doi.org\/10.1167\/iovs.17-22829.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"3848_CR211","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1089\/jop.2007.0002","volume":"23","author":"J Xu","year":"2007","unstructured":"Xu J, Wang Y, Li Y, Yang X, Zhang P, Hou H, et al. Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model. J Ocul Pharmacol Ther. 2007;23(6):527\u201340. https:\/\/doi.org\/10.1089\/jop.2007.0002.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"3848_CR212","doi-asserted-by":"publisher","first-page":"41","DOI":"10.18502\/jovr.v19i1.15436","volume":"19","author":"F Chaharband","year":"2024","unstructured":"Chaharband F, Varshochian R, Dinarvand R, Sabbaghi H, Rezaei Kanavi M, Daftarian N, et al. Polymeric Propranolol nanoparticles for intraocular delivery: formulation, characterization, and vitreous pharmacokinetics. J Ophthalmic Vis Res. 2024;19(1):41\u201350. https:\/\/doi.org\/10.18502\/jovr.v19i1.15436.","journal-title":"J Ophthalmic Vis Res"},{"key":"3848_CR213","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jconrel.2015.01.001","volume":"200","author":"VA Huu","year":"2015","unstructured":"Huu VA, Luo J, Zhu J, Zhu J, Patel S, Boone A, et al. Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye. J Control Release. 2015;200:71\u20137. https:\/\/doi.org\/10.1016\/j.jconrel.2015.01.001.","journal-title":"J Control Release"},{"key":"3848_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121379","volume":"612","author":"G Esteruelas","year":"2022","unstructured":"Esteruelas G, Halbaut L, Garc\u00eda-Torra V, Espina M, Cano A, Ettcheto M, et al. Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment. Int J Pharm. 2022;612:121379. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121379.","journal-title":"Int J Pharm"},{"key":"3848_CR215","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201701808","author":"E S\u00e1nchez-L\u00f3pez","year":"2018","unstructured":"S\u00e1nchez-L\u00f3pez E, Egea MA, Davis BM, Guo L, Espina M, Silva AM, et al. Memantine-loaded PEGylated biodegradable nanoparticles for the treatment of glaucoma. Small. 2018. https:\/\/doi.org\/10.1002\/smll.201701808.","journal-title":"Small"},{"issue":"3","key":"3848_CR216","doi-asserted-by":"publisher","first-page":"592","DOI":"10.22037\/ijpr.2021.114478.15054","volume":"20","author":"FU Khan","year":"2021","unstructured":"Khan FU, Nasir F, Iqbal Z, Neau S, Khan I, Hassan M, et al. Improved ocular bioavailability of Moxifloxacin HCl using PLGA nanoparticles: fabrication, characterization, in-vitro and in-vivo evaluation. Iran J Pharm Res. 2021;20(3):592\u2013608. https:\/\/doi.org\/10.22037\/ijpr.2021.114478.15054.","journal-title":"Iran J Pharm Res"},{"key":"3848_CR217","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16081092","author":"N Beirampour","year":"2024","unstructured":"Beirampour N, Bustos-Salgado P, Garr\u00f3s N, Mohammadi-Meyabadi R, Dom\u00e8nech \u00d2, Su\u00f1er-Carb\u00f3 J, et al. Formulation of polymeric nanoparticles loading baricitinib as a topical approach in ocular application. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16081092.","journal-title":"Pharmaceutics"},{"issue":"13","key":"3848_CR218","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1080\/09205063.2019.1625524","volume":"30","author":"J Pinto","year":"2019","unstructured":"Pinto J, Ahmad M, Guru BR. Enhancing the efficacy of Fluocinolone acetonide by encapsulating with PLGA nanoparticles and conjugating with linear PEG polymer. J Biomater Sci Polym Ed. 2019;30(13):1188\u2013211. https:\/\/doi.org\/10.1080\/09205063.2019.1625524.","journal-title":"J Biomater Sci Polym Ed"},{"issue":"6","key":"3848_CR219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21691401.2016.1203794","volume":"45","author":"AK Sah","year":"2017","unstructured":"Sah AK, Suresh PK, Verma VK. PLGA nanoparticles for ocular delivery of Loteprednol etabonate: a corneal penetration study. Artif Cells Nanomed Biotechnol. 2017;45(6):1\u20139. https:\/\/doi.org\/10.1080\/21691401.2016.1203794.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3848_CR220","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15122752","author":"P Bustos-Salgado","year":"2023","unstructured":"Bustos-Salgado P, Dom\u00ednguez-Villegas V, Andrade-Carrera B, Mallandrich M, Calpena A, Dom\u00e8nech O, et al. PLGA nanoparticles containing natural flavanones for ocular inflammation. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15122752.","journal-title":"Pharmaceutics"},{"key":"3848_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122982","volume":"639","author":"RM Galindo-Camacho","year":"2023","unstructured":"Galindo-Camacho RM, Haro I, G\u00f3mara MJ, Espina M, Fonseca J, Martins-Gomes C, et al. Cell penetrating peptides-functionalized Licochalcone-A-loaded PLGA nanoparticles for ocular inflammatory diseases: evaluation of in vitro anti-proliferative effects, stabilization by freeze-drying and characterization of an in-situ forming gel. Int J Pharm. 2023;639:122982. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122982.","journal-title":"Int J Pharm"},{"issue":"23","key":"3848_CR222","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.2217\/nnm-2019-0201","volume":"14","author":"R Gonzalez-Pizarro","year":"2019","unstructured":"Gonzalez-Pizarro R, Parrotta G, Vera R, S\u00e1nchez-L\u00f3pez E, Galindo R, Kjeldsen F, et al. Ocular penetration of fluorometholone-loaded PEG-PLGA nanoparticles functionalized with cell-penetrating peptides. Nanomedicine (Lond). 2019;14(23):3089\u2013104. https:\/\/doi.org\/10.2217\/nnm-2019-0201.","journal-title":"Nanomedicine (Lond)"},{"issue":"9","key":"3848_CR223","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1166\/jbn.2013.1646","volume":"9","author":"C Yang","year":"2013","unstructured":"Yang C, Jiang L, Bu S, Zhang L, Xie X, Zeng Q, et al. Intravitreal administration of dexamethasone-loaded PLGA-TPGS nanoparticles for the treatment of posterior segment diseases. J Biomed Nanotechnol. 2013;9(9):1617\u201323. https:\/\/doi.org\/10.1166\/jbn.2013.1646.","journal-title":"J Biomed Nanotechnol"},{"key":"3848_CR224","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.ijbiomac.2020.09.185","volume":"163","author":"MS Shahab","year":"2020","unstructured":"Shahab MS, Rizwanullah M, Alshehri S, Imam SS. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: in vitro, ex vivo and toxicity assessments. Int J Biol Macromol. 2020;163:2392\u2013404. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.09.185.","journal-title":"Int J Biol Macromol"},{"issue":"32","key":"3848_CR225","doi-asserted-by":"publisher","first-page":"11754","DOI":"10.1039\/c7nr03221h","volume":"9","author":"CH Lee","year":"2017","unstructured":"Lee CH, Li YJ, Huang CC, Lai JY. Poly(\u03b5-caprolactone) nanocapsule carriers with sustained drug release: single dose for long-term glaucoma treatment. Nanoscale. 2017;9(32):11754\u201364. https:\/\/doi.org\/10.1039\/c7nr03221h.","journal-title":"Nanoscale"},{"issue":"15","key":"3848_CR226","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.2174\/1389201021666200519133350","volume":"21","author":"GNS Girgis","year":"2020","unstructured":"Girgis GNS. Formulation and evaluation of atorvastatin calcium-poly-\u03b5-caprolactone nanoparticles loaded ocular inserts for sustained release and antiinflammatory efficacy. Curr Pharm Biotechnol. 2020;21(15):1688\u201398. https:\/\/doi.org\/10.2174\/1389201021666200519133350.","journal-title":"Curr Pharm Biotechnol"},{"issue":"2","key":"3848_CR227","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jconrel.2009.10.031","volume":"142","author":"H Kim","year":"2010","unstructured":"Kim H, Csaky KG. Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats. J Control Release. 2010;142(2):286\u201393. https:\/\/doi.org\/10.1016\/j.jconrel.2009.10.031.","journal-title":"J Control Release"},{"key":"3848_CR228","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13050687","author":"A Romeo","year":"2021","unstructured":"Romeo A, Musumeci T, Carbone C, Bonaccorso A, Corvo S, Lupo G, et al. Ferulic acid-loaded polymeric nanoparticles for potential ocular delivery. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13050687.","journal-title":"Pharmaceutics"},{"issue":"6","key":"3848_CR229","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1166\/jbn.2010.1168","volume":"6","author":"RC Nagarwal","year":"2010","unstructured":"Nagarwal RC, Singh PN, Kant S, Maiti P, Pandit JK. Chitosan coated PLA nanoparticles for ophthalmic delivery: characterization, in-vitro and in-vivo study in rabbit eye. J Biomed Nanotechnol. 2010;6(6):648\u201357. https:\/\/doi.org\/10.1166\/jbn.2010.1168.","journal-title":"J Biomed Nanotechnol"},{"key":"3848_CR230","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.exer.2013.04.007","volume":"112","author":"A Giarmoukakis","year":"2013","unstructured":"Giarmoukakis A, Labiris G, Sideroudi H, Tsimali Z, Koutsospyrou N, Avgoustakis K, et al. Biodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: in vitro and in vivo evaluation. Preliminary results. Exp Eye Res. 2013;112:29\u201336. https:\/\/doi.org\/10.1016\/j.exer.2013.04.007.","journal-title":"Exp Eye Res"},{"issue":"4","key":"3848_CR231","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.exer.2005.09.003","volume":"82","author":"T Sakai","year":"2006","unstructured":"Sakai T, Kohno H, Ishihara T, Higaki M, Saito S, Matsushima M, et al. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Exp Eye Res. 2006;82(4):657\u201363. https:\/\/doi.org\/10.1016\/j.exer.2005.09.003.","journal-title":"Exp Eye Res"},{"key":"3848_CR232","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111956","author":"A Bonaccorso","year":"2021","unstructured":"Bonaccorso A, Pepe V, Zappulla C, Cimino C, Pricoco A, Puglisi G, et al. Sorafenib repurposing for ophthalmic delivery by lipid nanoparticles: a preliminary study. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13111956.","journal-title":"Pharmaceutics"},{"key":"3848_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108906","volume":"215","author":"Z Cheng","year":"2022","unstructured":"Cheng Z, Li Y, Wang K, Zhu X, Tharkar P, Shu W, et al. Compritol solid lipid nanoparticle formulations enhance the protective effect of betulinic acid derivatives in human M\u00fcller cells against oxidative injury. Exp Eye Res. 2022;215:108906. https:\/\/doi.org\/10.1016\/j.exer.2021.108906.","journal-title":"Exp Eye Res"},{"key":"3848_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114296","volume":"199","author":"X Cao","year":"2024","unstructured":"Cao X, Su L, Chen H. A potent bioreducible ionizable lipid nanoparticle enables siRNA delivery for retinal neovascularization inhibition. Eur J Pharm Biopharm. 2024;199:114296. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114296.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"3848_CR235","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2217\/nnm-2018-0278","volume":"14","author":"M Singh","year":"2019","unstructured":"Singh M, Guzman-Aranguez A, Hussain A, Srinivas CS, Kaur IP. Solid lipid nanoparticles for ocular delivery of isoniazid: evaluation, proof of concept and in vivo safety & kinetics. Nanomed (Lond). 2019;14(4):465\u201391. https:\/\/doi.org\/10.2217\/nnm-2018-0278.","journal-title":"Nanomed (Lond)"},{"issue":"6","key":"3848_CR236","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/1061186x.2020.1871483","volume":"29","author":"S Kakkar","year":"2021","unstructured":"Kakkar S, Singh M, Mohan Karuppayil S, Raut JS, Giansanti F, Papucci L, et al. Lipo-PEG nano-ocular formulation successfully encapsulates hydrophilic fluconazole and traverses corneal and non-corneal path to reach posterior eye segment. J Drug Target. 2021;29(6):631\u201350. https:\/\/doi.org\/10.1080\/1061186x.2020.1871483.","journal-title":"J Drug Target"},{"key":"3848_CR237","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091961","author":"E Zingale","year":"2022","unstructured":"Zingale E, Rizzo S, Bonaccorso A, Consoli V, Vanella L, Musumeci T, et al. Optimization of lipid nanoparticles by response surface methodology to improve the ocular delivery of diosmin: characterization and in-vitro anti-inflammatory assessment. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14091961.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3848_CR238","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1080\/10717544.2021.1902023","volume":"28","author":"E Abd-Elhakeem","year":"2021","unstructured":"Abd-Elhakeem E, El-Nabarawi M, Shamma R. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy: in-vitro optimization and ex-vivo assessment. Drug Deliv. 2021;28(1):642\u201354. https:\/\/doi.org\/10.1080\/10717544.2021.1902023.","journal-title":"Drug Deliv"},{"issue":"10","key":"3848_CR239","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.1166\/jnn.2020.18569","volume":"20","author":"S Du","year":"2020","unstructured":"Du S, Wang H, Jiang F, Wang Y. Diabetic retinopathy analysis-effects of nanoparticle-based triamcinolone. J Nanosci Nanotechnol. 2020;20(10):6111\u20135. https:\/\/doi.org\/10.1166\/jnn.2020.18569.","journal-title":"J Nanosci Nanotechnol"},{"key":"3848_CR240","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030951","author":"D Santonocito","year":"2023","unstructured":"Santonocito D, Barbagallo I, Distefano A, Sferrazzo G, Vivero-Lopez M, Sarpietro MG, et al. Nanostructured lipid carriers aimed to the ocular delivery of mangiferin: in vitro evidence. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15030951.","journal-title":"Pharmaceutics"},{"issue":"12","key":"3848_CR241","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1166\/jbn.2013.1711","volume":"9","author":"NS Elbialy","year":"2013","unstructured":"Elbialy NS, Abdol-Azim BM, Shafaa MW, El Shazly LH, El Shazly AH, Khalil WA. Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment. J Biomed Nanotechnol. 2013;9(12):2105\u201316. https:\/\/doi.org\/10.1166\/jbn.2013.1711.","journal-title":"J Biomed Nanotechnol"},{"key":"3848_CR242","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316864","author":"C Bonechi","year":"2023","unstructured":"Bonechi C, Mahdizadeh FF, Talarico L, Pepi S, Tamasi G, Leone G, et al. Liposomal encapsulation of citicoline for ocular drug delivery. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242316864.","journal-title":"Int J Mol Sci"},{"key":"3848_CR243","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2147\/ijn.S446425","volume":"19","author":"C Sun","year":"2024","unstructured":"Sun C, Zhang S, Xu N, Liu K, Wei F, Zhang X, et al. Topical ophthalmic liposomes Dual-Modified with penetratin and hyaluronic acid for the noninvasive treatment of neovascular Age-Related macular degeneration. Int J Nanomed. 2024;19:1887\u2013908. https:\/\/doi.org\/10.2147\/ijn.S446425.","journal-title":"Int J Nanomed"},{"key":"3848_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113560","volume":"231","author":"X Peng","year":"2023","unstructured":"Peng X, Zhang T, Wu Y, Wang X, Liu R, Jin X. MPEG-CS-modified flexible liposomes-reinforced thermosensitive sol-gel reversible hydrogels for ocular delivery of multiple drugs with enhanced synergism. Colloids Surf B Biointerfaces. 2023;231:113560. https:\/\/doi.org\/10.1016\/j.colsurfb.2023.113560.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3848_CR245","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116776","volume":"175","author":"X Chen","year":"2024","unstructured":"Chen X, Liu S, Chen M, Ni N, Zhou R, Wang Y, et al. Novel therapeutic perspectives for wet age-related macular degeneration: RGD-modified liposomes loaded with 2-deoxy-D-glucose as a promising nanomedicine. Biomed Pharmacother. 2024;175:116776. https:\/\/doi.org\/10.1016\/j.biopha.2024.116776.","journal-title":"Biomed Pharmacother"},{"key":"3848_CR246","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121725","volume":"620","author":"S Tavakoli","year":"2022","unstructured":"Tavakoli S, Puranen J, Bahrpeyma S, Lautala VE, Karumo S, Lajunen T, et al. Liposomal sunitinib for ocular drug delivery: a potential treatment for choroidal neovascularization. Int J Pharm. 2022;620:121725. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121725.","journal-title":"Int J Pharm"},{"issue":"1","key":"3848_CR247","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1080\/10717544.2018.1474967","volume":"25","author":"H Mu","year":"2018","unstructured":"Mu H, Wang Y, Chu Y, Jiang Y, Hua H, Chu L, et al. Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization. Drug Deliv. 2018;25(1):1372\u201383. https:\/\/doi.org\/10.1080\/10717544.2018.1474967.","journal-title":"Drug Deliv"},{"key":"3848_CR248","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123958","volume":"654","author":"U Farooq","year":"2024","unstructured":"Farooq U, O\u2019Reilly NJ, Ahmed Z, Gasco P, Raghu Raj Singh T, Behl G, et al. Design of liposomal nanocarriers with a potential for combined dexamethasone and bevacizumab delivery to the eye. Int J Pharm. 2024;654:123958. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123958.","journal-title":"Int J Pharm"},{"key":"3848_CR249","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114717","volume":"163","author":"G Christensen","year":"2023","unstructured":"Christensen G, Chen Y, Urimi D, Zizmare L, Trautwein C, Schipper N, et al. Pyruvate-conjugation of PEGylated liposomes for targeted drug delivery to retinal photoreceptors. Biomed Pharmacother. 2023;163:114717. https:\/\/doi.org\/10.1016\/j.biopha.2023.114717.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"3848_CR250","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1007\/s13346-024-01584-z","volume":"14","author":"M Brugnera","year":"2024","unstructured":"Brugnera M, Vicario-de-la-Torre M, Gonz\u00e1lez-Cela Casamayor MA, L\u00f3pez-Cano JJ, Bravo-Osuna I, Huete-Toral F, et al. Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents. Drug Deliv Transl Res. 2024;14(10):2804\u201322. https:\/\/doi.org\/10.1007\/s13346-024-01584-z.","journal-title":"Drug Deliv Transl Res"},{"key":"3848_CR251","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122987","volume":"641","author":"Z Li","year":"2023","unstructured":"Li Z, Yu H, Liu C, Wang C, Zeng X, Yan J, et al. Efficiency co-delivery of ellagic acid and oxygen by a non-invasive liposome for ameliorating diabetic retinopathy. Int J Pharm. 2023;641:122987. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122987.","journal-title":"Int J Pharm"},{"key":"3848_CR252","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.partic.2021.11.007","volume":"69","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhu S, Gu Z, Chen C, Zhao Y. Toxicity of manufactured nanomaterials. Particuology. 2022;69:31\u201348. https:\/\/doi.org\/10.1016\/j.partic.2021.11.007.","journal-title":"Particuology"},{"issue":"1","key":"3848_CR253","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1186\/s12951-024-02901-x","volume":"22","author":"X Ma","year":"2024","unstructured":"Ma X, Tian Y, Yang R, Wang H, Allahou LW, Chang J, et al. Nanotechnology in healthcare, and its safety and environmental risks. J Nanobiotechnol. 2024;22(1):715. https:\/\/doi.org\/10.1186\/s12951-024-02901-x.","journal-title":"J Nanobiotechnol"},{"issue":"51","key":"3848_CR254","doi-asserted-by":"publisher","first-page":"17666","DOI":"10.1021\/la303449d","volume":"28","author":"S Nangia","year":"2012","unstructured":"Nangia S, Sureshkumar R. Effects of nanoparticle charge and shape anisotropy on translocation through cell membranes. Langmuir. 2012;28(51):17666\u201371. https:\/\/doi.org\/10.1021\/la303449d.","journal-title":"Langmuir"},{"issue":"1","key":"3848_CR255","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41427-021-00320-0","volume":"13","author":"X Zhang","year":"2021","unstructured":"Zhang X, Ma G, Wei W. Simulation of nanoparticles interacting with a cell membrane: probing the structural basis and potential biomedical application. NPG Asia Mater. 2021;13(1):52. https:\/\/doi.org\/10.1038\/s41427-021-00320-0.","journal-title":"NPG Asia Mater"},{"issue":"3","key":"3848_CR256","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3109\/17435390.2010.483745","volume":"4","author":"W Liu","year":"2010","unstructured":"Liu W, Wu Y, Wang C, Li HC, Wang T, Liao CY, et al. Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology. 2010;4(3):319\u201330. https:\/\/doi.org\/10.3109\/17435390.2010.483745.","journal-title":"Nanotoxicology"},{"issue":"4","key":"3848_CR257","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jat.2957","volume":"34","author":"A Avalos","year":"2014","unstructured":"Avalos A, Haza AI, Mateo D, Morales P. Cytotoxicity and ROS production of manufactured silver nanoparticles of different sizes in hepatoma and leukemia cells. J Appl Toxicol. 2014;34(4):413\u201323. https:\/\/doi.org\/10.1002\/jat.2957.","journal-title":"J Appl Toxicol"},{"key":"3848_CR258","doi-asserted-by":"publisher","first-page":"27902","DOI":"10.1038\/srep27902","volume":"6","author":"D Kov\u00e1cs","year":"2016","unstructured":"Kov\u00e1cs D, Igaz N, Keskeny C, B\u00e9lteky P, T\u00f3th T, G\u00e1sp\u00e1r R, et al. Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis. Sci Rep. 2016;6:27902. https:\/\/doi.org\/10.1038\/srep27902.","journal-title":"Sci Rep"},{"issue":"3","key":"3848_CR259","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/nano5031351","volume":"5","author":"SW Shin","year":"2015","unstructured":"Shin SW, Song IH, Um SH. Role of physicochemical properties in nanoparticle toxicity. Nanomaterials. 2015;5(3):1351\u201365. https:\/\/doi.org\/10.3390\/nano5031351.","journal-title":"Nanomaterials"},{"issue":"9","key":"3848_CR260","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941\u201351. https:\/\/doi.org\/10.1038\/nbt.3330.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"3848_CR261","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1021\/mp800049w","volume":"5","author":"SD Li","year":"2008","unstructured":"Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm. 2008;5(4):496\u2013504. https:\/\/doi.org\/10.1021\/mp800049w.","journal-title":"Mol Pharm"},{"issue":"2","key":"3848_CR262","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","volume":"53","author":"SM Moghimi","year":"2001","unstructured":"Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2):283\u2013318.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"3848_CR263","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12989-021-00429-8","volume":"18","author":"X Jin","year":"2021","unstructured":"Jin X, Yu H, Zhang Z, Cui T, Wu Q, Liu X, et al. Surface charge-dependent mitochondrial response to similar intracellular nanoparticle contents at sublethal dosages. Part Fibre Toxicol. 2021;18(1):36. https:\/\/doi.org\/10.1186\/s12989-021-00429-8.","journal-title":"Part Fibre Toxicol"},{"issue":"5","key":"3848_CR264","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1021\/nn901869f","volume":"4","author":"E Hutter","year":"2010","unstructured":"Hutter E, Boridy S, Labrecque S, Lalancette-H\u00e9bert M, Kriz J, Winnik FM, et al. Microglial response to gold nanoparticles. ACS Nano. 2010;4(5):2595\u2013606. https:\/\/doi.org\/10.1021\/nn901869f.","journal-title":"ACS Nano"},{"issue":"4","key":"3848_CR265","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/cpr.12192","volume":"48","author":"XR Shao","year":"2015","unstructured":"Shao XR, Wei XQ, Song X, Hao LY, Cai XX, Zhang ZR, et al. Independent effect of polymeric nanoparticle zeta potential\/surface charge, on their cytotoxicity and affinity to cells. Cell Prolif. 2015;48(4):465\u201374. https:\/\/doi.org\/10.1111\/cpr.12192.","journal-title":"Cell Prolif"},{"issue":"7","key":"3848_CR266","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1021\/bm101482r","volume":"12","author":"ZG Yue","year":"2011","unstructured":"Yue ZG, Wei W, Lv PP, Yue H, Wang LY, Su ZG, et al. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules. 2011;12(7):2440\u20136. https:\/\/doi.org\/10.1021\/bm101482r.","journal-title":"Biomacromolecules"},{"key":"3848_CR267","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2019.01.002","volume":"143","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, Ukidve A, Krishnan V, Mitragotri S. Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers. Adv Drug Deliv Rev. 2019;143:3\u201321. https:\/\/doi.org\/10.1016\/j.addr.2019.01.002.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"3848_CR268","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3109\/17435390.2010.539713","volume":"5","author":"MG Bexiga","year":"2011","unstructured":"Bexiga MG, Varela JA, Wang F, Fenaroli F, Salvati A, Lynch I, et al. Cationic nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human astrocytoma cell line. Nanotoxicology. 2011;5(4):557\u201367. https:\/\/doi.org\/10.3109\/17435390.2010.539713.","journal-title":"Nanotoxicology"},{"issue":"1","key":"3848_CR269","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1186\/s12951-024-02954-y","volume":"22","author":"EP Cisneros","year":"2024","unstructured":"Cisneros EP, Morse BA, Savk A, Malik K, Peppas NA, Lanier OL. The role of patient-specific variables in protein Corona formation and therapeutic efficacy in nanomedicine. J Nanobiotechnol. 2024;22(1):714. https:\/\/doi.org\/10.1186\/s12951-024-02954-y.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3848_CR270","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12951-023-02134-4","volume":"21","author":"S Capolla","year":"2023","unstructured":"Capolla S, Colombo F, De Maso L, Mauro P, Bertoncin P, K\u00e4hne T, et al. Surface antibody changes protein Corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles. J Nanobiotechnol. 2023;21(1):376. https:\/\/doi.org\/10.1186\/s12951-023-02134-4.","journal-title":"J Nanobiotechnol"},{"issue":"8","key":"3848_CR271","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.nano.2013.04.010","volume":"9","author":"F Wang","year":"2013","unstructured":"Wang F, Yu L, Monopoli MP, Sandin P, Mahon E, Salvati A, et al. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine. 2013;9(8):1159\u201368. https:\/\/doi.org\/10.1016\/j.nano.2013.04.010.","journal-title":"Nanomedicine"},{"issue":"7","key":"3848_CR272","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1021\/nn300223w","volume":"6","author":"A Lesniak","year":"2012","unstructured":"Lesniak A, Fenaroli F, Monopoli MP, \u00c5berg C, Dawson KA, Salvati A. Effects of the presence or absence of a protein Corona on silica nanoparticle uptake and impact on cells. ACS Nano. 2012;6(7):5845\u201357. https:\/\/doi.org\/10.1021\/nn300223w.","journal-title":"ACS Nano"},{"issue":"1","key":"3848_CR273","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1021\/acsomega.8b03227","volume":"4","author":"C Carnovale","year":"2019","unstructured":"Carnovale C, Bryant G, Shukla R, Bansal V. Identifying trends in gold nanoparticle toxicity and uptake: size, shape, capping ligand, and biological Corona. ACS Omega. 2019;4(1):242\u201356. https:\/\/doi.org\/10.1021\/acsomega.8b03227.","journal-title":"ACS Omega"},{"issue":"22","key":"3848_CR274","doi-asserted-by":"publisher","first-page":"10868","DOI":"10.1039\/c3nr03249c","volume":"5","author":"F Wang","year":"2013","unstructured":"Wang F, Bexiga MG, Anguissola S, Boya P, Simpson JC, Salvati A, et al. Time resolved study of cell death mechanisms induced by amine-modified polystyrene nanoparticles. Nanoscale. 2013;5(22):10868\u201376. https:\/\/doi.org\/10.1039\/c3nr03249c.","journal-title":"Nanoscale"},{"issue":"3","key":"3848_CR275","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1021\/bc060077y","volume":"17","author":"S Hong","year":"2006","unstructured":"Hong S, Leroueil PR, Janus EK, Peters JL, Kober MM, Islam MT, et al. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem. 2006;17(3):728\u201334. https:\/\/doi.org\/10.1021\/bc060077y.","journal-title":"Bioconjug Chem"},{"issue":"1","key":"3848_CR276","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3109\/17435390.2011.558643","volume":"6","author":"P Ruenraroengsak","year":"2012","unstructured":"Ruenraroengsak P, Novak P, Berhanu D, Thorley AJ, Valsami-Jones E, Gorelik J, et al. Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles. Nanotoxicology. 2012;6(1):94\u2013108. https:\/\/doi.org\/10.3109\/17435390.2011.558643.","journal-title":"Nanotoxicology"},{"issue":"32","key":"3848_CR277","doi-asserted-by":"publisher","first-page":"11179","DOI":"10.1021\/jp9033936","volume":"113","author":"J Chen","year":"2009","unstructured":"Chen J, Hessler JA, Putchakayala K, Panama BK, Khan DP, Hong S, et al. Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes. J Phys Chem B. 2009;113(32):11179\u201385. https:\/\/doi.org\/10.1021\/jp9033936.","journal-title":"J Phys Chem B"},{"issue":"1","key":"3848_CR278","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00342-0","volume":"5","author":"X Fu","year":"2020","unstructured":"Fu X, Shi Y, Qi T, Qiu S, Huang Y, Zhao X, et al. Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting. Signal Transduct Target Ther. 2020;5(1):262. https:\/\/doi.org\/10.1038\/s41392-020-00342-0.","journal-title":"Signal Transduct Target Ther"},{"key":"3848_CR279","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jconrel.2018.11.014","volume":"294","author":"J Song","year":"2019","unstructured":"Song J, Lin C, Yang X, Xie Y, Hu P, Li H, et al. Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted berberine derivative for cancer treatment by inducing mitochondrial apoptosis pathways. J Control Release. 2019;294:27\u201342. https:\/\/doi.org\/10.1016\/j.jconrel.2018.11.014.","journal-title":"J Control Release"},{"issue":"8","key":"3848_CR280","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.1007\/s12035-016-0133-7","volume":"54","author":"AK Sharma","year":"2017","unstructured":"Sharma AK, Singh V, Gera R, Purohit MP, Ghosh D. Zinc oxide nanoparticle induces microglial death by NADPH-oxidase-independent reactive oxygen species as well as energy depletion. Mol Neurobiol. 2017;54(8):6273\u201386. https:\/\/doi.org\/10.1007\/s12035-016-0133-7.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"3848_CR281","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12951-019-0448-4","volume":"17","author":"MK Gopisetty","year":"2019","unstructured":"Gopisetty MK, Kov\u00e1cs D, Igaz N, R\u00f3nav\u00e1ri A, B\u00e9lteky P, R\u00e1zga Z, et al. Endoplasmic reticulum stress: major player in size-dependent inhibition of P-glycoprotein by silver nanoparticles in multidrug-resistant breast cancer cells. J Nanobiotechnol. 2019;17(1):9. https:\/\/doi.org\/10.1186\/s12951-019-0448-4.","journal-title":"J Nanobiotechnol"},{"key":"3848_CR282","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25225336","author":"AA Khan","year":"2020","unstructured":"Khan AA, Allemailem KS, Almatroudi A, Almatroodi SA, Mahzari A, Alsahli MA, et al. Endoplasmic reticulum stress provocation by different nanoparticles: an innovative approach to manage the cancer and other common diseases. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25225336.","journal-title":"Molecules"},{"issue":"3","key":"3848_CR283","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1021\/nn406184r","volume":"8","author":"R Chen","year":"2014","unstructured":"Chen R, Huo L, Shi X, Bai R, Zhang Z, Zhao Y, et al. Endoplasmic reticulum stress induced by zinc oxide nanoparticles is an earlier biomarker for nanotoxicological evaluation. ACS Nano. 2014;8(3):2562\u201374. https:\/\/doi.org\/10.1021\/nn406184r.","journal-title":"ACS Nano"},{"issue":"9","key":"3848_CR284","doi-asserted-by":"publisher","first-page":"5926","DOI":"10.1074\/jbc.M114.610899","volume":"290","author":"JC Simard","year":"2015","unstructured":"Simard JC, Vallieres F, de Liz R, Lavastre V, Girard D. Silver nanoparticles induce degradation of the endoplasmic reticulum stress sensor activating transcription factor-6 leading to activation of the NLRP-3 inflammasome. J Biol Chem. 2015;290(9):5926\u201339. https:\/\/doi.org\/10.1074\/jbc.M114.610899.","journal-title":"J Biol Chem"},{"issue":"11","key":"3848_CR285","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s10495-016-1285-7","volume":"21","author":"JC Simard","year":"2016","unstructured":"Simard JC, Durocher I, Girard D. Silver nanoparticles induce irremediable endoplasmic reticulum stress leading to unfolded protein response dependent apoptosis in breast cancer cells. Apoptosis. 2016;21(11):1279\u201390. https:\/\/doi.org\/10.1007\/s10495-016-1285-7.","journal-title":"Apoptosis"},{"issue":"7","key":"3848_CR286","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/15548627.2018.1458174","volume":"14","author":"J Wang","year":"2018","unstructured":"Wang J, Li Y, Duan J, Yang M, Yu Y, Feng L, et al. Silica nanoparticles induce autophagosome accumulation via activation of the EIF2AK3 and ATF6 UPR pathways in hepatocytes. Autophagy. 2018;14(7):1185\u2013200. https:\/\/doi.org\/10.1080\/15548627.2018.1458174.","journal-title":"Autophagy"},{"issue":"12","key":"3848_CR287","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1021\/nn2027775","volume":"5","author":"YY Tsai","year":"2011","unstructured":"Tsai YY, Huang YH, Chao YL, Hu KY, Chin LT, Chou SH, et al. Identification of the Nanogold particle-induced endoplasmic reticulum stress by omic techniques and systems biology analysis. ACS Nano. 2011;5(12):9354\u201369. https:\/\/doi.org\/10.1021\/nn2027775.","journal-title":"ACS Nano"},{"issue":"19","key":"3848_CR288","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202307679","volume":"36","author":"T He","year":"2024","unstructured":"He T, Wen J, Wang W, Hu Z, Ling C, Zhao Z, et al. Peptide-driven proton Sponge nano-assembly for imaging and triggering lysosome-regulated immunogenic cancer cell death. Adv Mater. 2024;36(19):e2307679. https:\/\/doi.org\/10.1002\/adma.202307679.","journal-title":"Adv Mater"},{"issue":"1","key":"3848_CR289","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1021\/acsnano.8b05151","volume":"13","author":"M Wojnilowicz","year":"2019","unstructured":"Wojnilowicz M, Glab A, Bertucci A, Caruso F, Cavalieri F. Super-resolution imaging of proton Sponge-Triggered rupture of endosomes and cytosolic release of small interfering RNA. ACS Nano. 2019;13(1):187\u2013202. https:\/\/doi.org\/10.1021\/acsnano.8b05151.","journal-title":"ACS Nano"},{"key":"3848_CR290","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejpb.2018.05.034","volume":"129","author":"LMP Vermeulen","year":"2018","unstructured":"Vermeulen LMP, De Smedt SC, Remaut K, Braeckmans K. The proton sponge hypothesis: fable or fact? Eur J Pharm Biopharm. 2018;129:184\u201390. https:\/\/doi.org\/10.1016\/j.ejpb.2018.05.034.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3848_CR291","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abk2855","volume":"8","author":"Y Rui","year":"2022","unstructured":"Rui Y, Wilson DR, Tzeng SY, Yamagata HM, Sudhakar D, Conge M, et al. High-throughput and high-content bioassay enables tuning of polyester nanoparticles for cellular uptake, endosomal escape, and systemic in vivo delivery of mRNA. Sci Adv. 2022;8(1):eabk2855. https:\/\/doi.org\/10.1126\/sciadv.abk2855.","journal-title":"Sci Adv"},{"issue":"1","key":"3848_CR292","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jfda.2014.01.005","volume":"22","author":"PP Fu","year":"2014","unstructured":"Fu PP, Xia Q, Hwang HM, Ray PC, Yu H. Mechanisms of nanotoxicity: generation of reactive oxygen species. J Food Drug Anal. 2014;22(1):64\u201375. https:\/\/doi.org\/10.1016\/j.jfda.2014.01.005.","journal-title":"J Food Drug Anal"},{"issue":"1","key":"3848_CR293","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s11671-020-03344-7","volume":"15","author":"Z Yu","year":"2020","unstructured":"Yu Z, Li Q, Wang J, Yu Y, Wang Y, Zhou Q, et al. Reactive oxygen species-related nanoparticle toxicity in the biomedical field. Nanoscale Res Lett. 2020;15(1):115. https:\/\/doi.org\/10.1186\/s11671-020-03344-7.","journal-title":"Nanoscale Res Lett"},{"key":"3848_CR294","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/ijn.S36111","volume":"7","author":"E Fr\u00f6hlich","year":"2012","unstructured":"Fr\u00f6hlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed. 2012;7:5577\u201391. https:\/\/doi.org\/10.2147\/ijn.S36111.","journal-title":"Int J Nanomed"},{"issue":"1","key":"3848_CR295","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8(1):359. https:\/\/doi.org\/10.1038\/s41392-023-01588-0.","journal-title":"Signal Transduct Target Ther"},{"issue":"20","key":"3848_CR296","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101526","volume":"8","author":"C Li","year":"2021","unstructured":"Li C, Zhao Z, Luo Y, Ning T, Liu P, Chen Q, et al. Macrophage-disguised manganese dioxide nanoparticles for neuroprotection by reducing oxidative stress and modulating inflammatory microenvironment in acute ischemic stroke. Adv Sci. 2021;8(20):e2101526. https:\/\/doi.org\/10.1002\/advs.202101526.","journal-title":"Adv Sci"},{"issue":"21","key":"3848_CR297","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201808361","volume":"31","author":"Y Lu","year":"2019","unstructured":"Lu Y, Li C, Chen Q, Liu P, Guo Q, Zhang Y, et al. Microthrombus-targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke. Adv Mater. 2019;31(21):e1808361. https:\/\/doi.org\/10.1002\/adma.201808361.","journal-title":"Adv Mater"},{"key":"3848_CR298","doi-asserted-by":"publisher","unstructured":"Simpson DSA, Oliver PL. ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease. Antioxid (Basel). 2020;9(8). https:\/\/doi.org\/10.3390\/antiox9080743.","DOI":"10.3390\/antiox9080743"},{"key":"3848_CR299","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.envres.2014.11.006","volume":"136","author":"CL Huang","year":"2015","unstructured":"Huang CL, Hsiao IL, Lin HC, Wang CF, Huang YJ, Chuang CY. Silver nanoparticles affect on gene expression of inflammatory and neurodegenerative responses in mouse brain neural cells. Environ Res. 2015;136:253\u201363. https:\/\/doi.org\/10.1016\/j.envres.2014.11.006.","journal-title":"Environ Res"},{"issue":"2","key":"3848_CR300","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2217\/nnm-2017-0270","volume":"13","author":"T Wu","year":"2018","unstructured":"Wu T, Tang M. The inflammatory response to silver and titanium dioxide nanoparticles in the central nervous system. Nanomed (Lond). 2018;13(2):233\u201349. https:\/\/doi.org\/10.2217\/nnm-2017-0270.","journal-title":"Nanomed (Lond)"},{"issue":"7\u20138","key":"3848_CR301","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3109\/02699052.2013.793401","volume":"27","author":"Y Liu","year":"2013","unstructured":"Liu Y, Xu Z, Li X. Cytotoxicity of titanium dioxide nanoparticles in rat neuroglia cells. Brain Inj. 2013;27(7\u20138):934\u20139. https:\/\/doi.org\/10.3109\/02699052.2013.793401.","journal-title":"Brain Inj"},{"issue":"3","key":"3848_CR302","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.survophthal.2016.12.004","volume":"62","author":"ME Hartnett","year":"2017","unstructured":"Hartnett ME. Advances in understanding and management of retinopathy of prematurity. Surv Ophthalmol. 2017;62(3):257\u201376. https:\/\/doi.org\/10.1016\/j.survophthal.2016.12.004.","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"3848_CR303","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1161\/strokeaha.112.659656","volume":"43","author":"X Hu","year":"2012","unstructured":"Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, et al. Microglia\/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke. 2012;43(11):3063\u201370. https:\/\/doi.org\/10.1161\/strokeaha.112.659656.","journal-title":"Stroke"},{"issue":"7","key":"3848_CR304","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kam TI, Panicker N, Kim S, Oh Y, Park JS, et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of parkinson\u2019s disease. Nat Med. 2018;24(7):931\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0051-5.","journal-title":"Nat Med"},{"issue":"7999","key":"3848_CR305","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41586-023-06935-3","volume":"626","author":"EG Cameron","year":"2024","unstructured":"Cameron EG, Nahmou M, Toth AB, Heo L, Tanasa B, Dalal R, et al. A molecular switch for neuroprotective astrocyte reactivity. Nature. 2024;626(7999):574\u201382. https:\/\/doi.org\/10.1038\/s41586-023-06935-3.","journal-title":"Nature"},{"issue":"1","key":"3848_CR306","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12974-024-03190-9","volume":"21","author":"L Zhou","year":"2024","unstructured":"Zhou L, Xu Z, Lu H, Cho H, Xie Y, Lee G, et al. Suppression of inner blood-retinal barrier breakdown and pathogenic M\u00fcller glia activation in ischemia retinopathy by myeloid cell depletion. J Neuroinflammation. 2024;21(1):210. https:\/\/doi.org\/10.1186\/s12974-024-03190-9.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3848_CR307","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1021\/acs.biomac.2c01381","volume":"24","author":"I Pitha","year":"2023","unstructured":"Pitha I, Kambhampati S, Sharma A, Sharma R, McCrea L, Mozzer A, et al. Targeted microglial attenuation through dendrimer-drug conjugates improves glaucoma neuroprotection. Biomacromolecules. 2023;24(3):1355\u201365. https:\/\/doi.org\/10.1021\/acs.biomac.2c01381.","journal-title":"Biomacromolecules"},{"issue":"1","key":"3848_CR308","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0175-y","volume":"12","author":"R Natoli","year":"2017","unstructured":"Natoli R, Fernando N, Madigan M, Chu-Tan JA, Valter K, Provis J, et al. Microglia-derived IL-1\u03b2 promotes chemokine expression by M\u00fcller cells and RPE in focal retinal degeneration. Mol Neurodegener. 2017;12(1):31. https:\/\/doi.org\/10.1186\/s13024-017-0175-y.","journal-title":"Mol Neurodegener"},{"key":"3848_CR309","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12974-014-0224-1","volume":"12","author":"M Rutar","year":"2015","unstructured":"Rutar M, Natoli R, Chia RX, Valter K, Provis JM. Chemokine-mediated inflammation in the degenerating retina is coordinated by M\u00fcller cells, activated microglia, and retinal pigment epithelium. J Neuroinflammation. 2015;12:8. https:\/\/doi.org\/10.1186\/s12974-014-0224-1.","journal-title":"J Neuroinflammation"},{"issue":"11","key":"3848_CR310","doi-asserted-by":"publisher","first-page":"e7945","DOI":"10.1371\/journal.pone.0007945","volume":"4","author":"W Ma","year":"2009","unstructured":"Ma W, Zhao L, Fontainhas AM, Fariss RN, Wong WT. Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS One. 2009;4(11):e7945. https:\/\/doi.org\/10.1371\/journal.pone.0007945.","journal-title":"PLoS One"},{"key":"3848_CR311","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnana.2017.00077","volume":"11","author":"T Zhou","year":"2017","unstructured":"Zhou T, Huang Z, Sun X, Zhu X, Zhou L, Li M, et al. Microglia polarization with M1\/M2 phenotype changes in rd1 mouse model of retinal degeneration. Front Neuroanat. 2017;11:77. https:\/\/doi.org\/10.3389\/fnana.2017.00077.","journal-title":"Front Neuroanat"},{"issue":"6","key":"3848_CR312","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.preteyeres.2008.09.003","volume":"27","author":"C Kaur","year":"2008","unstructured":"Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res. 2008;27(6):622\u201347. https:\/\/doi.org\/10.1016\/j.preteyeres.2008.09.003.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3848_CR313","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13098-024-01282-3","volume":"16","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yang X, Zhang Y, Hong L, Xie Z, Jiang W, et al. Single-cell RNA sequencing reveals roles of unique retinal microglia types in early diabetic retinopathy. Diabetol Metab Syndr. 2024;16(1):49. https:\/\/doi.org\/10.1186\/s13098-024-01282-3.","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"3848_CR314","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/glia.23542","volume":"67","author":"DH Jo","year":"2019","unstructured":"Jo DH, Yun JH, Cho CS, Kim JH, Kim JH, Cho CH. Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy. Glia. 2019;67(2):321\u201331. https:\/\/doi.org\/10.1002\/glia.23542.","journal-title":"Glia"},{"issue":"8","key":"3848_CR315","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1167\/iovs.14-16250","volume":"56","author":"SP Kambhampati","year":"2015","unstructured":"Kambhampati SP, Clunies-Ross AJ, Bhutto I, Mishra MK, Edwards M, McLeod DS, et al. Systemic and intravitreal delivery of dendrimers to activated microglia\/macrophage in ischemia\/reperfusion mouse retina. Invest Ophthalmol Vis Sci. 2015;56(8):4413\u201324. https:\/\/doi.org\/10.1167\/iovs.14-16250.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3848_CR316","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202000181","author":"H Cho","year":"2021","unstructured":"Cho H, Kambhampati SP, Lai MJ, Zhou L, Lee G, Xie Y, et al. Dendrimer-triamcinolone acetonide reduces neuroinflammation, pathological angiogenesis, and neuroretinal dysfunction in ischemic retinopathy. Adv Ther. 2021. https:\/\/doi.org\/10.1002\/adtp.202000181.","journal-title":"Adv Ther"},{"issue":"1","key":"3848_CR317","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-023-03943-0","volume":"18","author":"G Unnikrishnan","year":"2023","unstructured":"Unnikrishnan G, Joy A, Megha M, Kolanthai E, Senthilkumar M. Exploration of inorganic nanoparticles for revolutionary drug delivery applications: a critical review. Discover Nano. 2023;18(1):157. https:\/\/doi.org\/10.1186\/s11671-023-03943-0.","journal-title":"Discover Nano"},{"issue":"12","key":"3848_CR318","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1021\/acsabm.2c00809","volume":"5","author":"CS Shin","year":"2022","unstructured":"Shin CS, Veettil RA, Sakthivel TS, Adumbumkulath A, Lee R, Zaheer M, et al. Noninvasive delivery of self-regenerating cerium oxide nanoparticles to modulate oxidative stress in the retina. ACS Appl Bio Mater. 2022;5(12):5816\u201325. https:\/\/doi.org\/10.1021\/acsabm.2c00809.","journal-title":"ACS Appl Bio Mater"},{"issue":"6","key":"3848_CR319","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.preteyeres.2007.07.004","volume":"26","author":"X He","year":"2007","unstructured":"He X, Hahn P, Iacovelli J, Wong R, King C, Bhisitkul R, et al. Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res. 2007;26(6):649\u201373. https:\/\/doi.org\/10.1016\/j.preteyeres.2007.07.004.","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"3848_CR320","doi-asserted-by":"publisher","first-page":"e9675","DOI":"10.7759\/cureus.9675","volume":"12","author":"J Kieffer","year":"2020","unstructured":"Kieffer J, Singh S, Dhillon BS, Kumar U, Shaikh S, Ho S, et al. Ceria nanoparticles mitigate the iron oxidative toxicity of human retinal pigment epithelium. Cureus. 2020;12(8):e9675. https:\/\/doi.org\/10.7759\/cureus.9675.","journal-title":"Cureus"},{"issue":"6","key":"3848_CR321","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1177\/08853282211030150","volume":"36","author":"B Dhillon","year":"2022","unstructured":"Dhillon B, Singh S, Keifer J, Kumar U, Shaikh S, Ho S, et al. Ameliorating hydroxychloroquine induced retinal toxicity through cerium oxide nanoparticle treatments. J Biomater Appl. 2022;36(6):1033\u201341. https:\/\/doi.org\/10.1177\/08853282211030150.","journal-title":"J Biomater Appl"},{"key":"3848_CR322","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071617","author":"A Tisi","year":"2020","unstructured":"Tisi A, Flati V, Delle Monache S, Lozzi L, Passacantando M, Maccarone R. Nanoceria particles are an eligible candidate to prevent age-related macular degeneration by inhibiting retinal pigment epithelium cell death and autophagy alterations. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9071617.","journal-title":"Cells"},{"issue":"9","key":"3848_CR323","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408436","volume":"12","author":"M Xu","year":"2025","unstructured":"Xu M, Zhou Y, Xu Y, Shao A, Han H, Ye J. Supramolecular engineering of nanoceria for management and amelioration of age-related macular degeneration via the two-level blocking of oxidative stress and inflammation. Adv Sci. 2025;12(9):e2408436. https:\/\/doi.org\/10.1002\/advs.202408436.","journal-title":"Adv Sci"},{"key":"3848_CR324","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108169","volume":"199","author":"A Tisi","year":"2020","unstructured":"Tisi A, Passacantando M, Lozzi L, Maccarone R. Cerium oxide nanoparticles reduce the accumulation of autofluorescent deposits in light-induced retinal degeneration: insights for age-related macular degeneration. Exp Eye Res. 2020;199:108169. https:\/\/doi.org\/10.1016\/j.exer.2020.108169.","journal-title":"Exp Eye Res"},{"issue":"11","key":"3848_CR325","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1166\/jbn.2021.3190","volume":"17","author":"J Shao","year":"2021","unstructured":"Shao J, Wan J, Zhang F, Zhang L. Construction of hyaluronic acid-CeO\u2082 conjugated composite nanoparticles and their activity efficiency in diabetic retinopathy alleviation. J Biomed Nanotechnol. 2021;17(11):2219\u201325. https:\/\/doi.org\/10.1166\/jbn.2021.3190.","journal-title":"J Biomed Nanotechnol"},{"key":"3848_CR326","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.2147\/ijn.S305676","volume":"16","author":"Y Ma","year":"2021","unstructured":"Ma Y, Li P, Zhao L, Liu J, Yu J, Huang Y, et al. Size-Dependent cytotoxicity and reactive oxygen species of cerium oxide nanoparticles in human retinal pigment epithelia cells. Int J Nanomed. 2021;16:5333\u201341. https:\/\/doi.org\/10.2147\/ijn.S305676.","journal-title":"Int J Nanomed"},{"issue":"1","key":"3848_CR327","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/med.21509","volume":"39","author":"F Masse","year":"2019","unstructured":"Masse F, Ouellette M, Lamoureux G, Boisselier E. Gold nanoparticles in ophthalmology. Med Res Rev. 2019;39(1):302\u201327. https:\/\/doi.org\/10.1002\/med.21509.","journal-title":"Med Res Rev"},{"key":"3848_CR328","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102205","volume":"28","author":"R Singh","year":"2020","unstructured":"Singh R, Batoki JC, Ali M, Bonilha VL, Anand-Apte B. Inhibition of choroidal neovascularization by systemic delivery of gold nanoparticles. Nanomedicine. 2020;28:102205. https:\/\/doi.org\/10.1016\/j.nano.2020.102205.","journal-title":"Nanomedicine"},{"key":"3848_CR329","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010109","author":"CM Chan","year":"2019","unstructured":"Chan CM, Hsiao CY, Li HJ, Fang JY, Chang DC, Hung CF. The inhibitory effects of gold nanoparticles on VEGF-A-induced cell migration in choroid-retina endothelial cells. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms21010109.","journal-title":"Int J Mol Sci"},{"key":"3848_CR330","doi-asserted-by":"publisher","DOI":"10.3390\/polym13193324","author":"A Laradji","year":"2021","unstructured":"Laradji A, Karakocak BB, Kolesnikov AV, Kefalov VJ, Ravi N. Hyaluronic acid-based gold nanoparticles for the topical delivery of therapeutics to the retina and the retinal pigment epithelium. Polymers. 2021. https:\/\/doi.org\/10.3390\/polym13193324.","journal-title":"Polymers"},{"key":"3848_CR331","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111151","volume":"194","author":"V Dave","year":"2020","unstructured":"Dave V, Sharma R, Gupta C, Sur S. Folic acid modified gold nanoparticle for targeted delivery of Sorafenib tosylate towards the treatment of diabetic retinopathy. Colloids Surf B Biointerfaces. 2020;194:111151. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111151.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"24","key":"3848_CR332","doi-asserted-by":"publisher","first-page":"26267","DOI":"10.1021\/acsomega.4c02066","volume":"9","author":"J Li","year":"2024","unstructured":"Li J, Lv P, Xiao Z, Xiao J. Protective effects of bioactive compound-derived nanoparticle against diabetic retinopathy through the modulation of the NF-\u03baB signaling pathway. ACS Omega. 2024;9(24):26267\u201374. https:\/\/doi.org\/10.1021\/acsomega.4c02066.","journal-title":"ACS Omega"},{"issue":"2","key":"3848_CR333","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1039\/d0bm01063d","volume":"9","author":"F Chen","year":"2021","unstructured":"Chen F, Si P, de la Zerda A, Jokerst JV, Myung D. Gold nanoparticles to enhance ophthalmic imaging. Biomater Sci. 2021;9(2):367\u201390. https:\/\/doi.org\/10.1039\/d0bm01063d.","journal-title":"Biomater Sci"},{"key":"3848_CR334","doi-asserted-by":"crossref","unstructured":"Aumann S, Donner S, Fischer J, M\u00fcller F. Optical Coherence Tomography (OCT): Principle and Technical Realization. In: Bille JF, editor. High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics. Cham (CH): Springer Copyright 2019, The Author(s). 2019; 59\u201385.","DOI":"10.1007\/978-3-030-16638-0_3"},{"key":"3848_CR335","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.top065508","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Hong H, Cai W. Photoacoustic imaging. Cold Spring Harb Protoc. 2011. https:\/\/doi.org\/10.1101\/pdb.top065508.","journal-title":"Cold Spring Harb Protoc"},{"issue":"1","key":"3848_CR336","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1038\/s41598-019-42324-5","volume":"9","author":"VP Nguyen","year":"2019","unstructured":"Nguyen VP, Li Y, Qian W, Liu B, Tian C, Zhang W, et al. Contrast agent enhanced multimodal photoacoustic microscopy and optical coherence tomography for imaging of rabbit choroidal and retinal vessels in vivo. Sci Rep. 2019;9(1):5945. https:\/\/doi.org\/10.1038\/s41598-019-42324-5.","journal-title":"Sci Rep"},{"issue":"1","key":"3848_CR337","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41467-020-20276-z","volume":"12","author":"VP Nguyen","year":"2021","unstructured":"Nguyen VP, Qian W, Li Y, Liu B, Aaberg M, Henry J, et al. Chain-like gold nanoparticle clusters for multimodal photoacoustic microscopy and optical coherence tomography enhanced molecular imaging. Nat Commun. 2021;12(1):34. https:\/\/doi.org\/10.1038\/s41467-020-20276-z.","journal-title":"Nat Commun"},{"issue":"34","key":"3848_CR338","doi-asserted-by":"publisher","first-page":"40214","DOI":"10.1021\/acsami.1c03504","volume":"13","author":"VP Nguyen","year":"2021","unstructured":"Nguyen VP, Li Y, Henry J, Zhang W, Wang X, Paulus YM. Gold nanorod enhanced photoacoustic microscopy and optical coherence tomography of choroidal neovascularization. ACS Appl Mater Interfaces. 2021;13(34):40214\u201328. https:\/\/doi.org\/10.1021\/acsami.1c03504.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"31","key":"3848_CR339","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202302069","volume":"35","author":"VP Nguyen","year":"2023","unstructured":"Nguyen VP, Qian W, Zhe J, Henry J, Wang M, Liu B, et al. Renally clearable ultraminiature chain-like gold nanoparticle clusters for multimodal molecular imaging of choroidal neovascularization. Adv Mater. 2023;35(31):e2302069. https:\/\/doi.org\/10.1002\/adma.202302069.","journal-title":"Adv Mater"},{"issue":"3","key":"3848_CR340","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1039\/c0cs00018c","volume":"40","author":"N Khlebtsov","year":"2011","unstructured":"Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev. 2011;40(3):1647\u201371. https:\/\/doi.org\/10.1039\/c0cs00018c.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"3848_CR341","doi-asserted-by":"publisher","first-page":"19606","DOI":"10.1038\/s41598-025-03804-z","volume":"15","author":"AR Hajrasouliha","year":"2025","unstructured":"Hajrasouliha AR, McCall B, Gao Y, Gong SL, Robinson K, Izadian A. Toxicity analysis of gold nanoparticle formulations used for intraocular applications. Sci Rep. 2025;15(1):19606. https:\/\/doi.org\/10.1038\/s41598-025-03804-z.","journal-title":"Sci Rep"},{"issue":"15","key":"3848_CR342","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.1167\/iovs.16-19754","volume":"57","author":"YJ Roh","year":"2016","unstructured":"Roh YJ, Rho CR, Cho WK, Kang S. The antiangiogenic effects of gold nanoparticles on experimental choroidal neovascularization in mice. Invest Ophthalmol Vis Sci. 2016;57(15):6561\u20137. https:\/\/doi.org\/10.1167\/iovs.16-19754.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3848_CR343","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nano.2011.11.001","volume":"8","author":"G Vecchio","year":"2012","unstructured":"Vecchio G, Galeone A, Brunetti V, Maiorano G, Rizzello L, Sabella S, et al. Mutagenic effects of gold nanoparticles induce aberrant phenotypes in Drosophila melanogaster. Nanomedicine. 2012;8(1):1\u20137. https:\/\/doi.org\/10.1016\/j.nano.2011.11.001.","journal-title":"Nanomedicine"},{"key":"3848_CR344","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.112844","volume":"161","author":"V Modica","year":"2022","unstructured":"Modica V, Gl\u00e1vits R, Murbach TS, Endres JR, Hirka G, V\u00e9rtesi A, et al. A toxicological evaluation of 8\u201328 nm gold nanocrystals. Food Chem Toxicol. 2022;161:112844. https:\/\/doi.org\/10.1016\/j.fct.2022.112844.","journal-title":"Food Chem Toxicol"},{"key":"3848_CR345","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2024.503827","volume":"900","author":"L Ramos-Pan","year":"2024","unstructured":"Ramos-Pan L, Touzani A, Fern\u00e1ndez-Bert\u00f3lez N, Fraga S, Laffon B, Valdiglesias V. Impact of gold nanoparticle exposure on genetic material. Mutat Res-Genet Toxicol Environ Mutagen. 2024;900:503827. https:\/\/doi.org\/10.1016\/j.mrgentox.2024.503827.","journal-title":"Mutat Res-Genet Toxicol Environ Mutagen"},{"issue":"27","key":"3848_CR346","doi-asserted-by":"publisher","first-page":"10962","DOI":"10.1021\/acs.nanolett.5c02523","volume":"25","author":"A Gupta","year":"2025","unstructured":"Gupta A, Maity A, Ndugire W, Chakraborty S, Ghorpade MS, Hirschbiegel CM, et al. Engineered lipid coronas for gold nanoparticle-based bioorthogonal catalysis. Nano Lett. 2025;25(27):10962\u20139. https:\/\/doi.org\/10.1021\/acs.nanolett.5c02523.","journal-title":"Nano Lett"},{"issue":"1","key":"3848_CR347","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12951-025-03329-7","volume":"23","author":"L Lei","year":"2025","unstructured":"Lei L, Xu H, Li M, Du M, Chen Z. Dual-pathway tumor radiosensitization strategy based on engineered bacteria capable of targeted delivery of AuNPs and specific hypoxia alleviation. J Nanobiotechnol. 2025;23(1):254. https:\/\/doi.org\/10.1186\/s12951-025-03329-7.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3848_CR348","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12951-025-03132-4","volume":"23","author":"LY Zhang","year":"2025","unstructured":"Zhang LY, Chen XT, Li RT, Meng W, Huang GQ, Chen YJ, et al. Overcoming hypoxia-induced breast cancer drug resistance: a novel strategy using hollow gold-platinum bimetallic nanoshells. J Nanobiotechnol. 2025;23(1):85. https:\/\/doi.org\/10.1186\/s12951-025-03132-4.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3848_CR349","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1186\/s12951-024-02985-5","volume":"22","author":"Y Ye","year":"2024","unstructured":"Ye Y, Zheng Q, Wang Z, Wang S, Lu Z, Chu Q, et al. Metal-phenolic nanoparticles enhance low temperature photothermal therapy for bacterial biofilm in superficial infections. J Nanobiotechnol. 2024;22(1):713. https:\/\/doi.org\/10.1186\/s12951-024-02985-5.","journal-title":"J Nanobiotechnol"},{"issue":"12","key":"3848_CR350","doi-asserted-by":"publisher","first-page":"11823","DOI":"10.1021\/acsnano.4c14061","volume":"19","author":"J Nie","year":"2025","unstructured":"Nie J, Eom K, AlGhosain HM, Neifert A, Cherian A, Gerbaka GM, et al. Intravitreally injected plasmonic nanorods activate bipolar cells with patterned near-infrared laser projection. ACS Nano. 2025;19(12):11823\u201340. https:\/\/doi.org\/10.1021\/acsnano.4c14061.","journal-title":"ACS Nano"},{"issue":"8","key":"3848_CR351","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/s41551-023-01137-8","volume":"8","author":"R Yang","year":"2024","unstructured":"Yang R, Zhao P, Wang L, Feng C, Peng C, Wang Z, et al. Assessment of visual function in blind mice and monkeys with subretinally implanted nanowire arrays as artificial photoreceptors. Nat Biomed Eng. 2024;8(8):1018\u201339. https:\/\/doi.org\/10.1038\/s41551-023-01137-8.","journal-title":"Nat Biomed Eng"},{"issue":"2","key":"3848_CR352","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.nano.2014.09.014","volume":"11","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhao Q, Han N, Bai L, Li J, Liu J, et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine. 2015;11(2):313\u201327. https:\/\/doi.org\/10.1016\/j.nano.2014.09.014.","journal-title":"Nanomedicine"},{"issue":"5","key":"3848_CR353","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10856-018-6069-x","volume":"29","author":"M Manzano","year":"2018","unstructured":"Manzano M, Vallet-Reg\u00ed M. Mesoporous silica nanoparticles in nanomedicine applications. J Mater Sci Mater Med. 2018;29(5):65. https:\/\/doi.org\/10.1007\/s10856-018-6069-x.","journal-title":"J Mater Sci Mater Med"},{"key":"3848_CR354","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.2147\/ijn.S195504","volume":"14","author":"JG Sun","year":"2019","unstructured":"Sun JG, Jiang Q, Zhang XP, Shan K, Liu BH, Zhao C, et al. Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy. Int J Nanomed. 2019;14:1489\u2013501. https:\/\/doi.org\/10.2147\/ijn.S195504.","journal-title":"Int J Nanomed"},{"key":"3848_CR355","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jconrel.2024.07.022","volume":"373","author":"AM Elbedwehy","year":"2024","unstructured":"Elbedwehy AM, Wu J, Na HK, Baek A, Jung H, Kwon IH, et al. ROS-responsive charge reversal mesoporous silica nanoparticles as promising drug delivery system for neovascular retinal diseases. J Control Release. 2024;373:224\u201339. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.022.","journal-title":"J Control Release"},{"key":"3848_CR356","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108329","volume":"202","author":"S Supe","year":"2021","unstructured":"Supe S, Upadhya A, Singh K. Role of small interfering RNA (siRNA) in targeting ocular neovascularization: a review. Exp Eye Res. 2021;202:108329. https:\/\/doi.org\/10.1016\/j.exer.2020.108329.","journal-title":"Exp Eye Res"},{"issue":"1","key":"3848_CR357","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1124\/molpharm.124.000895","volume":"106","author":"GM Traber","year":"2024","unstructured":"Traber GM, Yu AM. The growing class of novel RNAi therapeutics. Mol Pharmacol. 2024;106(1):13\u201320. https:\/\/doi.org\/10.1124\/molpharm.124.000895.","journal-title":"Mol Pharmacol"},{"issue":"27","key":"3848_CR358","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2217\/nnm-2022-0255","volume":"17","author":"JF Grondek","year":"2022","unstructured":"Grondek JF, Huffman K, Lee EJ, Cavichini M, Warter A, FG PK, et al. Effective treatment of retinal neovascular leakage with fusogenic porous silicon nanoparticles delivering VEGF-siRNA. Nanomed (Lond). 2022;17(27):2089\u2013108. https:\/\/doi.org\/10.2217\/nnm-2022-0255.","journal-title":"Nanomed (Lond)"},{"key":"3848_CR359","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11082170","author":"L Vald\u00e9s-S\u00e1nchez","year":"2022","unstructured":"Vald\u00e9s-S\u00e1nchez L, Borrego-Gonz\u00e1lez S, Montero-S\u00e1nchez A, Massalini S, de la Cerda B, D\u00edaz-Cuenca A, et al. Mesoporous silica-based nanoparticles as non-viral gene delivery platform for treating retinitis pigmentosa. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11082170.","journal-title":"J Clin Med"},{"key":"3848_CR360","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bioactmat.2024.05.038","volume":"39","author":"A Shao","year":"2024","unstructured":"Shao A, Jin L, Ge Y, Ye Z, Xu M, Zhou Y, et al. C176-loaded and phosphatidylserine-modified nanoparticles treat retinal neovascularization by promoting M2 macrophage polarization. Bioact Mater. 2024;39:392\u2013405. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.05.038.","journal-title":"Bioact Mater"},{"key":"3848_CR361","doi-asserted-by":"publisher","DOI":"10.3390\/nu9030307","author":"BA Luo","year":"2017","unstructured":"Luo BA, Gao F, Qin LL. The association between vitamin D deficiency and diabetic retinopathy in type 2 diabetes: a meta-analysis of observational studies. Nutrients. 2017. https:\/\/doi.org\/10.3390\/nu9030307.","journal-title":"Nutrients"},{"issue":"2","key":"3848_CR362","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1021\/acsabm.3c01200","volume":"7","author":"S Sarkar","year":"2024","unstructured":"Sarkar S, Osman N, Thrimawithana T, Wann SB, Kalita J, Manna P. Alleviation of diabetic retinopathy by glucose-triggered delivery of vitamin D via dextran-gated functionalized mesoporous silica nanoparticles. ACS Appl Bio Mater. 2024;7(2):1260\u201370. https:\/\/doi.org\/10.1021\/acsabm.3c01200.","journal-title":"ACS Appl Bio Mater"},{"issue":"23","key":"3848_CR363","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801047","volume":"7","author":"C Hu","year":"2018","unstructured":"Hu C, Sun J, Zhang Y, Chen J, Lei Y, Sun X, et al. Local delivery and sustained-release of nitric oxide donor loaded in mesoporous silica particles for efficient treatment of primary open-angle glaucoma. Adv Healthc Mater. 2018;7(23):e1801047. https:\/\/doi.org\/10.1002\/adhm.201801047.","journal-title":"Adv Healthc Mater"},{"issue":"9","key":"3848_CR364","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202410166","volume":"21","author":"VP Nguyen","year":"2025","unstructured":"Nguyen VP, Jeong J, Zheng M, Lee J, Zhe J, Wei Z, et al. Long-term diabetic retinopathy treatment using silicon nanoneedles. Small. 2025;21(9):e2410166. https:\/\/doi.org\/10.1002\/smll.202410166.","journal-title":"Small"},{"key":"3848_CR365","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbrc.2023.06.083","volume":"674","author":"AH Kaynar","year":"2023","unstructured":"Kaynar AH, \u00c7\u00f6meleko\u011flu \u00dc, Kibar D, Y\u0131ld\u0131r\u0131m M, Y\u0131ld\u0131r\u0131mcan S, Y\u0131lmaz \u015eN, et al. Cytotoxic effect of silica nanoparticles on human retinal pigment epithelial cells. Biochem Biophys Res Commun. 2023;674:53\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2023.06.083.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3848_CR366","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12951-022-01326-8","volume":"20","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhao L, Ma Y, Liu J, Huang Y, Fu X, et al. Mechanistic study of silica nanoparticles on the size-dependent retinal toxicity in vitro and in vivo. J Nanobiotechnol. 2022;20(1):146. https:\/\/doi.org\/10.1186\/s12951-022-01326-8.","journal-title":"J Nanobiotechnol"},{"key":"3848_CR367","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01401","volume":"9","author":"D Maiti","year":"2018","unstructured":"Maiti D, Tong X, Mou X, Yang K. Carbon-based nanomaterials for biomedical applications: a recent study. Front Pharmacol. 2018;9:1401. https:\/\/doi.org\/10.3389\/fphar.2018.01401.","journal-title":"Front Pharmacol"},{"key":"3848_CR368","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/B978-0-08-102985-5.00018-8","volume-title":"Nanoengineered Biomaterials for Advanced Drug Delivery","author":"S Pattnaik","year":"2020","unstructured":"Pattnaik S, Surendra Y, Rao JV, Swain K. 18 - Carbon family nanomaterials for drug delivery applications. In: Mozafari M, editor. Nanoengineered Biomaterials for Advanced Drug Delivery. Elsevier; 2020. p. 421\u201345."},{"key":"3848_CR369","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.biopha.2016.12.108","volume":"87","author":"P Namdari","year":"2017","unstructured":"Namdari P, Negahdari B, Eatemadi A. Synthesis, properties and biomedical applications of carbon-based quantum dots: an updated review. Biomed Pharmacother. 2017;87:209\u201322. https:\/\/doi.org\/10.1016\/j.biopha.2016.12.108.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"3848_CR370","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202205754","volume":"19","author":"VB Kumar","year":"2023","unstructured":"Kumar VB, Sher I, Rencus-Lazar S, Rotenstreich Y, Gazit E. Functional carbon quantum Dots for ocular imaging and therapeutic applications. Small. 2023;19(7):e2205754. https:\/\/doi.org\/10.1002\/smll.202205754.","journal-title":"Small"},{"issue":"3","key":"3848_CR371","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1021\/acsami.2c18598","volume":"15","author":"I De Hoon","year":"2023","unstructured":"De Hoon I, Barras A, Swebocki T, Vanmeerhaeghe B, Bogaert B, Muntean C, et al. Influence of the size and charge of carbon quantum Dots on their corneal penetration and permeation enhancing properties. ACS Appl Mater Interfaces. 2023;15(3):3760\u201371. https:\/\/doi.org\/10.1021\/acsami.2c18598.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3848_CR372","doi-asserted-by":"publisher","first-page":"573407","DOI":"10.3389\/fbioe.2020.573407","volume":"8","author":"I Garner","year":"2020","unstructured":"Garner I, Vichare R, Paulson R, Appavu R, Panguluri SK, Tzekov R, et al. Carbon Dots fabrication: ocular imaging and therapeutic potential. Front Bioeng Biotechnol. 2020;8:573407. https:\/\/doi.org\/10.3389\/fbioe.2020.573407.","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"3848_CR373","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s10895-023-03200-8","volume":"33","author":"H Ilhan","year":"2023","unstructured":"Ilhan H, Erdem B, Ozkasapoglu S, Yayla M, Bas O, Celikkan H. Fluorescent and biocompatible nitrogen and sulfur co-doped carbon nanodot as an ocular fundus angiography imaging agent. J Fluoresc. 2023;33(5):1917\u201325. https:\/\/doi.org\/10.1007\/s10895-023-03200-8.","journal-title":"J Fluoresc"},{"issue":"41","key":"3848_CR374","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1021\/acs.biochem.5b00781","volume":"54","author":"RM Shereema","year":"2015","unstructured":"Shereema RM, Sruthi TV, Kumar VB, Rao TP, Shankar SS. Angiogenic profiling of synthesized carbon quantum Dots. Biochemistry. 2015;54(41):6352\u20136. https:\/\/doi.org\/10.1021\/acs.biochem.5b00781.","journal-title":"Biochemistry"},{"issue":"40","key":"3848_CR375","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201902776","volume":"15","author":"A Shoval","year":"2019","unstructured":"Shoval A, Markus A, Zhou Z, Liu X, Cazelles R, Willner I, et al. Anti-VEGF-aptamer modified C-dots-a hybrid nanocomposite for topical treatment of ocular vascular disorders. Small. 2019;15(40):e1902776. https:\/\/doi.org\/10.1002\/smll.201902776.","journal-title":"Small"},{"key":"3848_CR376","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189934","author":"L Wang","year":"2021","unstructured":"Wang L, Pan H, Gu D, Sun H, Chen K, Tan G, et al. A novel carbon dots\/thermo-sensitive in situ gel for a composite ocular drug delivery system: characterization, ex-vivo imaging, and in vivo evaluation. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22189934.","journal-title":"Int J Mol Sci"},{"key":"3848_CR377","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2147\/ijn.S440025","volume":"19","author":"Q Wang","year":"2024","unstructured":"Wang Q, Dong J, Du M, Liu X, Zhang S, Zhang D, et al. Chitosan-Rapamycin carbon Dots alleviate glaucomatous retinal injury by inducing autophagy to promote M2 microglial polarization. Int J Nanomed. 2024;19:2265\u201384. https:\/\/doi.org\/10.2147\/ijn.S440025.","journal-title":"Int J Nanomed"},{"issue":"11","key":"3848_CR378","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1021\/acsinfecdis.7b00150","volume":"3","author":"SG Harroun","year":"2017","unstructured":"Harroun SG, Lai JY, Huang CC, Tsai SK, Lin HJ. Reborn from the ashes: turning organic molecules to antimicrobial carbon quantum dots. ACS Infect Dis. 2017;3(11):777\u20139. https:\/\/doi.org\/10.1021\/acsinfecdis.7b00150.","journal-title":"ACS Infect Dis"},{"issue":"6","key":"3848_CR379","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s10895-021-02798-x","volume":"31","author":"SS Suner","year":"2021","unstructured":"Suner SS, Sahiner M, Ayyala RS, Bhethanabotla VR, Sahiner N. Versatile fluorescent carbon dots from citric acid and cysteine with antimicrobial, anti-biofilm, antioxidant, and ache enzyme inhibition capabilities. J Fluoresc. 2021;31(6):1705\u201317. https:\/\/doi.org\/10.1007\/s10895-021-02798-x.","journal-title":"J Fluoresc"},{"issue":"21","key":"3848_CR380","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201808283","volume":"31","author":"Y Yan","year":"2019","unstructured":"Yan Y, Gong J, Chen J, Zeng Z, Huang W, Pu K, et al. Recent advances on graphene quantum dots: from chemistry and physics to applications. Adv Mater. 2019;31(21):e1808283. https:\/\/doi.org\/10.1002\/adma.201808283.","journal-title":"Adv Mater"},{"issue":"1","key":"3848_CR381","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12951-020-00698-z","volume":"18","author":"C Zhao","year":"2020","unstructured":"Zhao C, Song X, Liu Y, Fu Y, Ye L, Wang N, et al. Synthesis of graphene quantum dots and their applications in drug delivery. J Nanobiotechnol. 2020;18(1):142. https:\/\/doi.org\/10.1186\/s12951-020-00698-z.","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"3848_CR382","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1039\/d4nh00282b","volume":"9","author":"FT Duvan","year":"2024","unstructured":"Duvan FT, Cunquero M, Masvidal-Codina E, Walston ST, Marsal M, de la Cruz JM, et al. Graphene-based microelectrodes with bidirectional functionality for next-generation retinal electronic interfaces. Nanoscale Horiz. 2024;9(11):1948\u201361. https:\/\/doi.org\/10.1039\/d4nh00282b.","journal-title":"Nanoscale Horiz"},{"issue":"1","key":"3848_CR383","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12951-022-01362-4","volume":"20","author":"N Zhao","year":"2022","unstructured":"Zhao N, Gui X, Fang Q, Zhang R, Zhu W, Zhang H, et al. Graphene quantum dots rescue angiogenic retinopathy via blocking STAT3\/Periostin\/ERK signaling. J Nanobiotechnol. 2022;20(1):174. https:\/\/doi.org\/10.1186\/s12951-022-01362-4.","journal-title":"J Nanobiotechnol"},{"key":"3848_CR384","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jphotobiol.2018.10.019","volume":"189","author":"C Qian","year":"2018","unstructured":"Qian C, Yan P, Wan G, Liang S, Dong Y, Wang J. Facile synthetic photoluminescent graphene quantum dots encapsulated \u03b2-cyclodextrin drug carrier system for the management of macular degeneration: detailed analytical and biological investigations. J Photochem Photobiol B. 2018;189:244\u20139. https:\/\/doi.org\/10.1016\/j.jphotobiol.2018.10.019.","journal-title":"J Photochem Photobiol B"},{"issue":"33","key":"3848_CR385","doi-asserted-by":"publisher","first-page":"14629","DOI":"10.1021\/acs.est.4c02179","volume":"58","author":"Y Liu","year":"2024","unstructured":"Liu Y, Tan X, Wang R, Fan L, Yan Q, Chen C, et al. Retinal degeneration response to graphene quantum dots: disruption of the blood-retina barrier modulated by surface modification-dependent DNA methylation. Environ Sci Technol. 2024;58(33):14629\u201340. https:\/\/doi.org\/10.1021\/acs.est.4c02179.","journal-title":"Environ Sci Technol"},{"key":"3848_CR386","doi-asserted-by":"publisher","DOI":"10.3390\/ma12040624","author":"J Simon","year":"2019","unstructured":"Simon J, Flahaut E, Golzio M. Overview of carbon nanotubes for biomedical applications. Materials. 2019. https:\/\/doi.org\/10.3390\/ma12040624.","journal-title":"Materials"},{"issue":"1","key":"3848_CR387","doi-asserted-by":"publisher","DOI":"10.1007\/s41061-019-0278-8","volume":"378","author":"V Negri","year":"2020","unstructured":"Negri V, Pacheco-Torres J, Calle D, L\u00f3pez-Larrubia P. Carbon nanotubes in biomedicine. Top Curr Chem. 2020;378(1):15. https:\/\/doi.org\/10.1007\/s41061-019-0278-8.","journal-title":"Top Curr Chem"},{"issue":"17","key":"3848_CR388","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1021\/acschemneuro.1c00242","volume":"12","author":"R Yang","year":"2021","unstructured":"Yang R, Yang S, Li K, Luo Z, Xian B, Tang J, et al. Carbon nanotube polymer scaffolds as a conductive alternative for the construction of retinal sheet tissue. ACS Chem Neurosci. 2021;12(17):3167\u201375. https:\/\/doi.org\/10.1021\/acschemneuro.1c00242.","journal-title":"ACS Chem Neurosci"},{"issue":"7","key":"3848_CR389","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302881","volume":"13","author":"HJ Jian","year":"2024","unstructured":"Jian HJ, Anand A, Lai JY, Huang CC, Ma DH, Lai CC, et al. Ultrahigh-efficacy VEGF neutralization using carbonized nanodonuts: implications for intraocular anti-angiogenic therapy. Adv Healthc Mater. 2024;13(7):e2302881. https:\/\/doi.org\/10.1002\/adhm.202302881.","journal-title":"Adv Healthc Mater"},{"key":"3848_CR390","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117619","volume":"241","author":"Y Liang","year":"2024","unstructured":"Liang Y, Zhou Y, Xie D, Yin F, Luo X. Hypermethylation and low expression of FANCC involved in multi-walled carbon nanotube-induced toxicity on ARPE-19 cells. Environ Res. 2024;241:117619. https:\/\/doi.org\/10.1016\/j.envres.2023.117619.","journal-title":"Environ Res"},{"key":"3848_CR391","doi-asserted-by":"publisher","DOI":"10.1186\/1477-3155-7-8","volume":"7","author":"S Sheikpranbabu","year":"2009","unstructured":"Sheikpranbabu S, Kalishwaralal K, Venkataraman D, Eom SH, Park J, Gurunathan S. Silver nanoparticles inhibit VEGF-and IL-1beta-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells. J Nanobiotechnology. 2009;7:8. https:\/\/doi.org\/10.1186\/1477-3155-7-8.","journal-title":"J Nanobiotechnology"},{"key":"3848_CR392","doi-asserted-by":"publisher","first-page":"10387","DOI":"10.2147\/ijn.S477011","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yuan B, Liu W, Cui J, Zhou X, Yuan L, et al. The Xaliproden nanoscale Zirconium-Porphyrin Metal-Organic framework (XAL-NPMOF) promotes photoreceptor regeneration following oxidative and inflammatory insults. Int J Nanomed. 2024;19:10387\u2013400. https:\/\/doi.org\/10.2147\/ijn.S477011.","journal-title":"Int J Nanomed"},{"issue":"1","key":"3848_CR393","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-023-01829-y","volume":"21","author":"W Su","year":"2023","unstructured":"Su W, Liu C, Jiang X, Lv Y, Chen Q, Shi J, et al. An intravitreal-injectable hydrogel depot doped borneol-decorated dual-drug-coloaded microemulsions for long-lasting retina delivery and synergistic therapy of wAMD. J Nanobiotechnol. 2023;21(1):71. https:\/\/doi.org\/10.1186\/s12951-023-01829-y.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3848_CR394","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12951-023-01794-6","volume":"21","author":"P Cao","year":"2023","unstructured":"Cao P, Cheng Y, Li Z, Cheng YJ, Chu X, Geng C, et al. Intraocular delivery of ZIF-90-RhB-GW2580 nanoparticles prevents the progression of photoreceptor degeneration. J Nanobiotechnol. 2023;21(1):44. https:\/\/doi.org\/10.1186\/s12951-023-01794-6.","journal-title":"J Nanobiotechnol"},{"key":"3848_CR395","doi-asserted-by":"publisher","first-page":"119961","DOI":"10.1016\/j.biomaterials.2020.119961","volume":"243","author":"LJ Luo","year":"2020","unstructured":"Luo LJ, Nguyen DD, Lai JY. Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: a push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy. Biomaterials. 2020;243:119961. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119961.","journal-title":"Biomaterials"},{"key":"3848_CR396","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232416191","author":"G Raiche-Marcoux","year":"2022","unstructured":"Raiche-Marcoux G, Loiseau A, Maranda C, Poliquin A, Boisselier E. Parametric drug release optimization of anti-inflammatory drugs by gold nanoparticles for topically applied ocular therapy. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232416191.","journal-title":"Int J Mol Sci"},{"key":"3848_CR397","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijbiomac.2018.01.123","volume":"110","author":"M Paulsamy","year":"2018","unstructured":"Paulsamy M, Ponnusamy C, Palanisami M, Nackeeran G, Paramasivam S, Sugumaran A, et al. Nepafenac loaded silica nanoparticles dispersed in-situ gel systems: development and characterization. Int J Biol Macromol. 2018;110:336\u201345. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.01.123.","journal-title":"Int J Biol Macromol"},{"key":"3848_CR398","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031260","author":"AA Alhowyan","year":"2023","unstructured":"Alhowyan AA, Kalam MA, Iqbal M, Raish M, El-Toni AM, Alkholief M, et al. Mesoporous silica nanoparticles coated with carboxymethyl chitosan for 5-fluorouracil ocular delivery: characterization, in vitro and in vivo studies. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28031260.","journal-title":"Molecules"},{"issue":"8","key":"3848_CR399","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1177\/0885328220977605","volume":"35","author":"MRB Paiva","year":"2021","unstructured":"Paiva MRB, Andrade GF, Dourado LFN, Castro BFM, Fialho SL, Sousa EMB, et al. Surface functionalized mesoporous silica nanoparticles for intravitreal application of tacrolimus. J Biomater Appl. 2021;35(8):1019\u201333. https:\/\/doi.org\/10.1177\/0885328220977605.","journal-title":"J Biomater Appl"},{"key":"3848_CR400","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123530","volume":"647","author":"M Shareef Khan","year":"2023","unstructured":"Shareef Khan M, Rao Ravi P, Shrikant Dhavan D. Design, optimization and pharmacokinetic evaluation of PLGA phosphatidylcholine hybrid nanoparticles of triamcinolone acetonide loaded in situ gel for topical ocular delivery. Int J Pharm. 2023;647:123530. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123530.","journal-title":"Int J Pharm"},{"key":"3848_CR401","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122195","volume":"627","author":"A Romeo","year":"2022","unstructured":"Romeo A, Bonaccorso A, Carbone C, Lupo G, Daniela Anfuso C, Giurdanella G, et al. Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model. Int J Pharm. 2022;627:122195. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122195.","journal-title":"Int J Pharm"},{"key":"3848_CR402","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123006","volume":"640","author":"B Kaviarasi","year":"2023","unstructured":"Kaviarasi B, Rajana N, Pooja YS, Rajalakshmi AN, Singh SB, Mehra NK. Investigating the effectiveness of Difluprednate-Loaded core-shell lipid-polymeric hybrid nanoparticles for ocular delivery. Int J Pharm. 2023;640:123006. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123006.","journal-title":"Int J Pharm"},{"key":"3848_CR403","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.111398","volume":"119","author":"ML Formica","year":"2021","unstructured":"Formica ML, Legeay S, Bejaud J, Montich GG, Ullio Gamboa GV, Benoit JP, et al. Novel hybrid lipid nanocapsules loaded with a therapeutic monoclonal antibody - Bevacizumab - and Triamcinolone acetonide for combined therapy in neovascular ocular pathologies. Mater Sci Eng C Mater Biol Appl. 2021;119:111398. https:\/\/doi.org\/10.1016\/j.msec.2020.111398.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1","key":"3848_CR404","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-024-04109-2","volume":"19","author":"PS Rawat","year":"2024","unstructured":"Rawat PS, Ravi PR, Mahajan RR. Design, pharmacokinetic, and pharmacodynamic evaluation of a lecithin-chitosan hybrid nanoparticle-loaded dual-responsive in situ gel of nebivolol for effective treatment of glaucoma. Discover Nano. 2024;19(1):156. https:\/\/doi.org\/10.1186\/s11671-024-04109-2.","journal-title":"Discover Nano"},{"key":"3848_CR405","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jphotobiol.2018.04.033","volume":"183","author":"J Yan","year":"2018","unstructured":"Yan J, Peng X, Cai Y, Cong W. Development of facile drug delivery platform of Ranibizumab fabricated PLGA-PEGylated magnetic nanoparticles for age-related macular degeneration therapy. J Photochem Photobiol B. 2018;183:133\u20136. https:\/\/doi.org\/10.1016\/j.jphotobiol.2018.04.033.","journal-title":"J Photochem Photobiol B"},{"issue":"12","key":"3848_CR406","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.1039\/c9nr00376b","volume":"11","author":"YJ Li","year":"2019","unstructured":"Li YJ, Luo LJ, Harroun SG, Wei SC, Unnikrishnan B, Chang HT, et al. Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease. Nanoscale. 2019;11(12):5580\u201394. https:\/\/doi.org\/10.1039\/c9nr00376b.","journal-title":"Nanoscale"},{"key":"3848_CR407","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102260","volume":"29","author":"S Schnichels","year":"2020","unstructured":"Schnichels S, Hurst J, de Vries JW, Ullah S, Gruszka A, Kwak M, et al. Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment. Nanomedicine. 2020;29:102260. https:\/\/doi.org\/10.1016\/j.nano.2020.102260.","journal-title":"Nanomedicine"},{"key":"3848_CR408","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2147\/dddt.S103505","volume":"11","author":"R Rajabalaya","year":"2017","unstructured":"Rajabalaya R, Musa MN, Kifli N, David SR. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals. Drug Des Devel Ther. 2017;11:393\u2013406. https:\/\/doi.org\/10.2147\/dddt.S103505.","journal-title":"Drug Des Devel Ther"},{"key":"3848_CR409","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123546","volume":"647","author":"VP Chavda","year":"2023","unstructured":"Chavda VP, Dyawanapelly S, Dawre S, Ferreira-Faria I, Bezbaruah R, Rani Gogoi N, et al. Lyotropic liquid crystalline phases: drug delivery and biomedical applications. Int J Pharm. 2023;647:123546. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123546.","journal-title":"Int J Pharm"},{"key":"3848_CR410","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051421","author":"JSL Leu","year":"2023","unstructured":"Leu JSL, Teoh JJX, Ling ALQ, Chong J, Loo YS, Mat Azmi ID, et al. Recent advances in the development of liquid crystalline nanoparticles as drug delivery systems. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15051421.","journal-title":"Pharmaceutics"},{"issue":"6","key":"3848_CR411","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1021\/acsnano.8b07961","volume":"13","author":"J Zhai","year":"2019","unstructured":"Zhai J, Fong C, Tran N, Drummond CJ. Non-lamellar lyotropic liquid crystalline lipid nanoparticles for the next generation of nanomedicine. ACS Nano. 2019;13(6):6178\u2013206. https:\/\/doi.org\/10.1021\/acsnano.8b07961.","journal-title":"ACS Nano"},{"key":"3848_CR412","doi-asserted-by":"publisher","DOI":"10.3390\/ph15040429","author":"M Chountoulesi","year":"2022","unstructured":"Chountoulesi M, Pispas S, Tseti IK, Demetzos C. Lyotropic liquid crystalline nanostructures as drug delivery systems and vaccine platforms. Pharmaceuticals (Basel). 2022. https:\/\/doi.org\/10.3390\/ph15040429.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"3848_CR413","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.drudis.2019.05.004","volume":"24","author":"T Madheswaran","year":"2019","unstructured":"Madheswaran T, Kandasamy M, Bose RJ, Karuppagounder V. Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems. Drug Discov Today. 2019;24(7):1405\u201312. https:\/\/doi.org\/10.1016\/j.drudis.2019.05.004.","journal-title":"Drug Discov Today"},{"key":"3848_CR414","doi-asserted-by":"publisher","DOI":"10.3390\/ph17101315","author":"S Adwan","year":"2024","unstructured":"Adwan S, Qasmieh M, Al-Akayleh F, Ali Agha ASA. Recent advances in ocular drug delivery: insights into lyotropic liquid crystals. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17101315.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"3848_CR415","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/jop.2024.0153","volume":"41","author":"T Sarkar","year":"2025","unstructured":"Sarkar T, Gogoi NR, Jana BK, Mazumder B. Formulation advances in posterior segment ocular drug delivery. J Ocul Pharmacol Ther. 2025;41(3):101\u201330. https:\/\/doi.org\/10.1089\/jop.2024.0153.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3848_CR416","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115082","volume":"201","author":"K Glover","year":"2023","unstructured":"Glover K, Mishra D, Gade S, Vora LK, Wu Y, Paredes AJ, et al. Microneedles for advanced ocular drug delivery. Adv Drug Deliv Rev. 2023;201:115082. https:\/\/doi.org\/10.1016\/j.addr.2023.115082.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3848_CR417","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13346-020-00740-5","volume":"10","author":"JM Metselaar","year":"2020","unstructured":"Metselaar JM, Lammers T. Challenges in nanomedicine clinical translation. Drug Deliv Transl Res. 2020;10(3):721\u20135. https:\/\/doi.org\/10.1007\/s13346-020-00740-5.","journal-title":"Drug Deliv Transl Res"},{"key":"3848_CR418","doi-asserted-by":"publisher","first-page":"100048","DOI":"10.1016\/j.onano.2022.100048","volume":"7","author":"Y Herdiana","year":"2022","unstructured":"Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Scale-up polymeric-based nanoparticles drug delivery systems: development and challenges. OpenNano. 2022;7:100048. https:\/\/doi.org\/10.1016\/j.onano.2022.100048.","journal-title":"OpenNano"},{"issue":"1","key":"3848_CR419","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12951-024-02363-1","volume":"22","author":"R Zhang","year":"2024","unstructured":"Zhang R, Li D, Zhao R, Luo D, Hu Y, Wang S, et al. Spike structure of gold nanobranches induces hepatotoxicity in mouse hepatocyte organoid models. J Nanobiotechnology. 2024;22(1):92. https:\/\/doi.org\/10.1186\/s12951-024-02363-1.","journal-title":"J Nanobiotechnology"},{"issue":"3","key":"3848_CR420","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1021\/acs.nanolett.3c02939","volume":"24","author":"A Baek","year":"2024","unstructured":"Baek A, Kwon IH, Lee DH, Choi WH, Lee SW, Yoo J, et al. Novel organoid culture system for improved safety assessment of nanomaterials. Nano Lett. 2024;24(3):805\u201313. https:\/\/doi.org\/10.1021\/acs.nanolett.3c02939.","journal-title":"Nano Lett"},{"issue":"11","key":"3848_CR421","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","volume":"19","author":"P Joyce","year":"2024","unstructured":"Joyce P, Allen CJ, Alonso MJ, Ashford M, Bradbury MS, Germain M, et al. A translational framework to DELIVER nanomedicines to the clinic. Nat Nanotechnol. 2024;19(11):1597\u2013611. https:\/\/doi.org\/10.1038\/s41565-024-01754-7.","journal-title":"Nat Nanotechnol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03848-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03848-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03848-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:05:37Z","timestamp":1768341937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03848-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":421,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3848"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03848-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}